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ABSTRACT

DNA methylation is a widely studied epigenetic modification that can influence
the expression and regulation of functional genes, especially those related to aging, cancer
and other diseases.

The common goal of methylation studies is to find differences in

methylation levels between samples collected under different conditions. Differences can
be detected at the site level, but regulated methylation targets are most commonly clustered
into short regions. Thus, identifying differentially methylated regions (DMRs) between
different groups is of prime interest. Despite advanced technology that enables measuring
methylation genome-wide, misinterpretations in the readings can arise due to the existence
of single nucleotide polymorphisms (SNPs) in the target sequence.

One of the main

pre-processing steps in DMR detection methods involves filtering out potential SNP-related
probes due to this issue. In this work, it is proposed to leverage the current trend of collecting
both SNP and methylation data on the same individual, making it possible to integrate SNP
data into the DNA methylation analysis framework. This will enable the originally filtered
potential SNPs to be restored if a SNP is not actually present. Furthermore, when a SNP is
present or other missing data issues arise, imputation methods are proposed for methylation
data. First, regularized linear regression (ridge, LASSO and elastic net) imputation models
are proposed, along with a variable screening technique to restrict the number of variables
in the models. Functional principal component regression imputation is also proposed as an
alternative approach. The proposed imputation methods are compared to existing methods
and evaluated based on imputation accuracy and DMR detection ability using both real and
simulated data. One of the proposed methods (elastic net with variable screening) shows
effective imputation accuracy without sacrificing computation efficiency across a variety of
settings, while greatly improving the number of true positive DMR detections.
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1. INTRODUCTION

1.1. EPIGENETICS AND DNA METHYLATION
Genetics is the study of heritable changes involving modifications of the DNA
sequence that exhibit variation between individuals. It includes the study of gene expression,
genetic changes and multiple gene interactions. Changes to the DNA sequence are called
mutations, and there are different types including deletions, insertions and translocations.
Mutations can sometimes lead to the malformation of proteins, which may lead to disease.
For example, sickle cell disease is caused by a single nucleotide mutation in the HBB gene
that provides instructions for making one part of hemoglobin (Schnog et al., 2004). On the
other hand, epigenetics is the study of heritable changes that are not associated with any
alteration of the DNA sequence. Although all cells in an organism contain the same genetic
information, the expression of genes can differ between cells. For example, different cell
types require different genes to be active to perform their functions. Gene expression is
regulated by epigenetics through different mechanisms, such as histone modifications, DNA
methylation and non-coding RNA (Wei et al., 2017).
1.1.1. Mechanisms of DNA Methylation. DNA methylation (DNAm) plays an
important role in gene regulation. It is one of the most studied epigenetic modifications
in human cells that can affect gene expression and preserve cellular states through cell
division without actually changing the DNA sequence. A nucleotide on a DNA molecule,
specifically a cytosine, is methylated when a methyl group ( - CH 3) is added to the carbon-5
position of a cytosine, forming 5-methylcytosine. In mammals, DNAm is almost exclu
sively found in CpG dinucleotides (a compound comprised of two nucleotides, cytosine
(C) and guanine (G)) (Moore et al., 2013). The "p" simply indicates that "C" and "G"
are connected by a phosphodiester bond. In stem cells and in plants, methylation is also
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found in the context of CHG and CHH where H is either A, T or C. A modified cytosine
was first discovered in mammals by Hotchkiss (1948), who hypothesized that it was 5methylcytosine and that it existed naturally in DNA. DNA methylation was demonstrated to
be involved in gene regulation and cell differentiation in the 1980s (Holliday and Pugh, 1975;
Compere and Palmiter, 1981). Further studies have revealed the important role of DNA
methylation in many biological processes; including genomic imprinting (Tycko, 1997),
transposable element silencing (Hollister and Gaut, 2009), stem cell differentiation (Sheaffer et al., 2014), embryonic development (Messerschmidt et al., 2014) and inflammation
(Bayarsaihan, 2011), as well as cancer (Bock, 2012) and several other diseases.
1.1.2. CpG Island. A CpG island is a short part of the DNA sequence with a
higher frequency of the CG dinucleotides sequence than other regions. CpG islands are
often defined as a region with at least 200 base pairs (bp), a C and G percentage greater
than 50%, and an observed-to-expected CpG ratio greater than 60% (Ongenaert, 2010).
More stringent criteria have been proposed because this definition was unable to distinguish
CpG islands from certain DNA repeat structures. Takai and Jones (2002) define a CpG
island as having a minimal length of 500 bp, an observed-to-expected CpG ratio greater
than 65%, and a C and G content of more than 55% are required. This largely solves the
repeat problem, with the drawback that CpG islands that are smaller than 500 bp can not be
predicted.
CpG islands typically occur at or near the transcription start site of genes, particularly
housekeeping genes, in vertebrates. About 70% of human gene promoters have high CpG
concentrations (Saxonov et al., 2006). DNA is wrapped around histone proteins forming
small, packaged sections called nucleosomes. One of the common features of CpG islands
is that they have less nucleosomes than other parts of DNA. This is often associated with
modified histones and results in enhancing gene expression (Tazi and Bird, 1990). The CG
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dinucleotides sequence is not typically methylated in the promoter region of active genes.
By contrast, the CG dinucleotides sequences in the promoter region of inactive genes are
usually methylated to suppress their expression (Vinson and Chatterjee, 2012).
1.1.3. DNA Methylation and Cancer. It is well recognized that DNA methylation
is an important epigenetic factor influencing gene activities, including genomic imprinting,
aging and carcinogenesis. Cancer cells must undergo a series of molecular-level events to
have the ability to replicate without limitation, as well as to invade and metastasize (Hanahan and Weinberg, 2011). Hypomethylation describes the unmethylated state of CpG sites
that are normally methylated (a decrease in methylation); whereas hypermethylation refers
to the methylated state of CpG sites in a specific sequence that are normally unmethylated
(an increase in methylation). In cancer, global hypomethylation is accompanied by hypermethylation of specific genes. Hypermethylation in the promoter regions of certain genes
can suppress the expression of their functional proteins, including known tumor suppressor
genes, leading to the silencing of those genes (Wajed et al., 2001). Epigenome-wide DNA
methylation studies have shown that the methylation within functional promoter areas was
associated with an increased risk of breast cancer, while the methylation of genomic regions
outside the promoters was associated with a decreased risk (Severi et al., 2014). However,
global hypomethylation has also been associated with oncogenesis (Das and Singal, 2004).
Studies are ongoing to investigate the relationship between methylation patterns across the
genome and specific types of cancer.

1.2. DNA METHYLATION TECHNOLOGIES
1.2.1. Bisulfite Sequencing. The development of technologies to measure levels
of DNA methylation throughout the genome has been substantial in the past 30 years.
These technological advances allow for significant improvement in understanding the role
of epigenetics in medicine and biology in general. One method to detect DNA methylation at
individual CpG sites is Bisulfite Sequencing combined with next generation sequencing (BS-
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seq) or whole genome bisulfite sequencing (WGBS). The basic principle of this approach
involves bisulfite conversion on the unmethylated cytosines. Bisulfite conversion is a process
in which DNA is denatured and treated with sodium bisulfite. The unmethylated cytosines
are converted to uracils, while methylated cytosines remain unchanged. Following this
process, the DNA is then treated by PCR amplification where the uracils are converted to
thymines (Frommer et al., 1992). Comparing the sequence of converted DNA to untreated
DNA creates a methylation profile of the sample. BS-seq or WGBS is the most thorough
and informative approach to measure methylation status, thus it is capable of revealing
subtle methylation patterns, and it achieves the most comprehensive coverage of a genome.
However, BS-seq is a costly and time-consuming procedure because the whole
genome is tested.

Reduced representation bisulfite sequencing (RRBS) is an efficient

alternative for analyzing the genome-wide methylation profiles on a single cytosine level
(Meissner et al., 2005). RRBS examines a subset of the genome by using a restriction
enzyme to extract regions with a high CG dinucleotides content. The amount of nucleotides
required to sequence is only 1% of the genome. These fragments often cover key promoter
regions and CpG islands. This makes RRBS more economical and efficient. Therefore
RRBS is suitable for large-scale comparative methylation studies across different tissues of
cell types. On the other hand, a limitation of RRBS is that it can miss some CG dinucleotides
and have lower coverage of some regions.
1.2.2. Infinium Beadchips. Illumina has developed a novel bead array technology
using silica microbeads. On the surface of each array, tiny silica beads are located in
microwells and coated with multiple probes. Probes are a collection of DNA spots that are
attached to the solid surface for hybridization with the labeled target. Different probes are
attached to each bead (Steemers and Gunderson, 2005). Illumina Infinium BeadChips have
provided an easy to use, time efficient and cost effective way to measure methylation levels.
The technology was first introduced with the Infinium HumanMethylation27 BeadChip
(HM27). Quantitative measurements of DNA methylation can be determined for 27,578
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CpG dinucleotides spanning 14,495 genes using the HM27 platform. Like BS-seq, the initial
step is bisulfite conversion, in which only a small amount of genomic DNA is required.
Next, each sample is amplified, enzymatically fragmented, purified and then applied to the
BeadChips for hybridization. There are two bead types that correspond to each CpG locus:
one for the methylated and the other for the unmethylated state. Then, the array is stained
with fluorescent dye and the intensities are measured (Weisenberger et al., 2008).
In 2011, an updated array called the Infinium HumanMethylation450 BeadChip
(HM450) became the most widely used method for DNA methylation profiling.

The

HM450 array features 485,577 probes in coding and non-coding DNA regions, covering
94% of the CpG sites on the HM27 array. Coverage is targeted to gene regions with sites
in the promoter region, 5’ UTR, first exon, gene body, and 3’ UTR of RefSeq genes. CpG
islands, CpG sites outside of CpG islands, and some enhancer regions are also covered by
the HM450 array, as well as differentially methylated sites identified in tumor versus normal
and across several tissue types. Notably, The Cancer Genome Atlas (TCGA) (TCGA, 2021)
consortium used the HM450 platform to profile more than 8500 samples from over 52
different cancer types.
There are two types of probes (Infinium I and Infinium II) on the HM450 array.
Both probe types have assay chemistry technologies that are utilized to enhance the depth
of coverage for methylation analysis. An illustration of the two probe types can be found
in Figure 1.1. The Infinium I assay, also used in HM27, employs two bead types per
CpG locus: one for the methylated and one for the unmethylated states. The Infinium II
design uses one bead type, with the methylated state determined at the single base extension
step. The addition of the Infinium II design enables each of up to three CpG sites to be
either methylated or unmethylated on the probe with no impact on the result for the queried
site. For the HM450 BeadChip, about 30% of CpG sites are measured using Infinium I
probes and 70% of CpG sites are measured by the Infinium II probes. In 2016, the new
Illumina Infinium Methylation EPIC array was released that can provide DNA methylation
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Figure 1.1. Two types of Infinium probes. The Infinium I probes (top) have two bead types:
one for the methylated and one for the unmethylated states. The Infinium II probes (bottom)
has one bead type with the methylated state determined at the single base extension step.
Figure from Illumina (2012).

levels for a total of 863,904 CpG sites. The EPIC array includes over 90% of the HM450
probes, as well as additional probes dedicated to the enhancers revealed by the Functional
Annotation of the Mammalian Genome project (FANTOM5) and the Encyclopedia of DNA
Elements project (ENCODE). FANTOM5 and ENCODE are both public research projects
aiming to identify functional elements in the human genome. Overall, data from the EPIC
array at single loci are highly reproducible across technical and biological replicates and
demonstrate high correlation with HM450 and WGBS data (Pidsley et al., 2016). In this

7
work, the HM450 platform is utilized since data are accessible from TCGA. However, the
methods can be generalized to methylation data obtained by other technologies, such as the
EPIC array, WGBS or RRBS.

1.3. SNP AND METHYLATION MICROARRAYS
A single-nucleotide polymorphism (SNP) is a single nucleotide substitution in the
DNA sequence (Figure 1.2). Typically there are two possible nucleotides altering at a
given position (Vignal et al., 2002). SNPs are a common type of genetic variation among
other DNA sequence mutations such as deletions, insertions and translocations. A variant is
classified as a SNP when more than 1% of the population does not share the same nucleotide
at the specific position on the genome. In humans, the occurrence rate of SNPs is about
0.1%, meaning that there is one SNP in every 1,200 to 1,500 base pairs (Shastry, 2002).
SNPs can occur anywhere in the genome, including in the coding regions of genes where
they could lead to the changes in gene function and expression. SNPs can be identified
through hybridization-based or enzyme-based methods.

A SNP array is one detection

method based on the hybridization of the fragmented DNA sequence and the immobilized
allele-specific oligonucleotide probes (LaFramboise, 2009). DNA methylation microarrays
also have a connection to SNP arrays. DNAm arrays interrogate DNA methylation states by
sodium bisulfite conversion which transforms an epigenetic difference between a modified
cytosine (including 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5hmC)) and
an unmodified cytosine to a genetic C/T SNP (Frommer et al., 1992). Therefore, the DNAm
microarrays are essentially SNP arrays because the Infinium arrays obtain the methylation
intensity at a particular location by checking whether there is a C/T SNP present.
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Figure 1.2. Single nucleotide polymorphism (SNP). At the fourth base, a SNP is present.
The DNA sequence varies within a population at this site.

1.4. PREPROCESSING OF METHYLATION DATA
1.4.1. Probe Filtering. Some probes on the Illumina methylation arrays (including
the HM450 array used in this work) are prone to giving inaccurate values that do not represent
the underlying methylation state. This can arise due to a number of different reasons, that
are each considered for initial filtering. One way this can happen is when a probe is present
in low quantities because of amplification artifacts or mutation, resulting in a mismatched
intended sequence. Such probes should be filtered out since they mostly carry background
noise. To distinguish signal from noise, detection p-values are used. The background
distribution is assumed normal, and the parameters are estimated using negative control
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probes. The p-value is computed using a Z-test (Heiss and Just, 2019). A small detection
p-value indicates that the measured intensity is very likely to be a true (significant) signal
and not background noise. Typically, significance levels of 0.05 or 0.01 are used.

A

sample is considered a bad sample when over 10% of the probes are problematic based on
the detection p-values, and should be removed from the analysis. Bead counts are also a
consideration of the probe quality. Usually, probes with less than 3 beads in at least 5% of
samples per probe are filtered out. A larger proportion of non-CpG-target probes (Probe
ID starting with “ch”) are potentially cross-hybridizing probes. Cross-hybridization is the
tendency for chains of nucleic acids to bind to other chains of nucleic acids that have similar
but not identical sequences. This makes the results difficult to interpret (Reilly et al., 2006).
Of the 3,091 non-CpG probes on the HM450 microarray, only 39% can be mapped with
a perfect match to the correct genomic location annotated by Illumina (Chen et al., 2013).
Thus, all non-CpG probes are filtered out. Moreover, there are 65 built-in SNP probes
(Probe ID starting with "rs") querying high-frequency SNPs in the HM450 array for the
purpose of quality control, and they are typically removed in preprocessing steps.
The existence of SNPs can affect DNA methylation readouts in the Infinium arrays.
SNPs can increase mismatches close to the 3’ end of the probe sequence and interfere with
successful extension. It can also change the CpG dinucleotide sequence and therefore the
ability of cytosines to be methylated. A special case would be the presence of an actual
C/T polymorphism instead of the C/T introduced by bisulfite conversion. Also, for a Type I
Infinium probe, the color channel depends on the extension base. If a SNP is present in the
extension base, a potential color change could happen. Specifically, the color switch can be
caused by an A/G SNP but not an A/T SNP, because A and T bases are both labeled with
red fluorophores, and C and G are labeled with green. Therefore, probes with any SNP of
global minor allele frequency (MAF) over 1% and within 5 bp from their targets, Infinium
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I probes with putative color channel switching SNPs, and Infinium II probes with SNPs of
global MAF over 1% affecting the extension base are suggested to be filtered out (Zhou
et al., 2016).
When aligning probe sequences to the human genome, some probes map to multiple
sites.

It has been shown that probes with non-unique alignments display significantly

greater variance in methylation levels than uniquely mapping probes (Nordlund et al., 2013).
Therefore, the multi-hit probes are usually filtered out in the preprocessing step. Typically,
probes located in chromosome X and Y are removed to avoid sex related methylation biases.
1.4.2.

Normalization. As mentioned in section 1.2, the Infinium HumanMethyla-

tion450 and the EPIC BeadChip use two different types of chemical assays for their probes.
This probe design can potentially cause problems for data analysis if they are not handled
properly. It is shown that Infinium I and II probes usually have different distributions
of methylation values, and that Infinium II probes are relatively less accurate and more
sensitive for detecting extreme methylation values (Dedeurwaerder et al., 2011). In order
to eliminate the influence of different probe types, remove sources of technical variation
between measurements, as well as cancel background noise of the data, several different
normalization methods have been developed.
Quantile normalization (Bolstad et al., 2003), first used in gene expression data, uses
the mean intensity of the probes with the same rank from all studied arrays to replace the
intensity of a probe. This helps make the distribution of probe intensities the same for each
array. A peak-based correction (PBC) method (Dedeurwaerder et al., 2011) estimates the
methylation peaks for the two probe types separately, then rescales the Infinium II values
according to the initial range of Infinium I. The subset-quantile within array normalization
(SWAN) method (Maksimovic et al., 2012) is based on normalization methods from mi
croarray gene expression platforms. An average quantile distribution is determined using a
subset of probes defined to be biologically similar based on CpG content. The intensities of
the remaining probes are then adjusted by interpolation onto the distribution of the subset
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probes. The yS-mixture quantile normalization (BMIQ) method (Teschendorff et al., 2013)
decomposes the methylation profiles of Infinium I and Infinium II probes into two mixtures
of three methylation states (unmethylated, partially methylated and fully methylated), and
then quantile normalizes the three distributions of the Infinium II profile corresponding to
those of the Infinium I profile.

1.5. DIFFERENTIAL METHYLATION TESTING
1.5.1. Site Level Testing. A common goal of methylation studies is to discover
individual CpG sites that have significantly different methylation levels between different
conditions (e.g., normal vs.

disease).

These differentially methylated sites can be of

substantial importance for the identification of novel disease biomarkers. In recent years,
many statistical methods were developed for different types of methylation data to detect
differentially methylated CpG sites.
For BS-seq, data can be summarized as counts of methylated and unmethylated
reads at any given site. Fisher's exact test (FET) was one of the first approaches used
to detect differentially methylated sites (Lister et al., 2009).

However, FET does not

account for the inherent biological variation that is present across biological replicates
and it assumes independence between cytosine sites. BSmooth (Hansen et al., 2012) is an
alternative approach that uses a “signal-to-noise” statistic to quantify differential methylation
evidence at individual CpG sites by combining top ranked differentially methylated cytosines
(DMCs), which are found using a t-statistic approach with either a quantile or direct t-statistic
cutoff. BSmooth is not used directly for inference of differential sites, but rather uses the
site level statistics to find differentially methylated regions. The beta-binomial model is an
alternative statistical model for replicated BS-seq DNA methylation measurements. The
beta-binomial distribution is the binomial distribution in which the probability of success
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in each of n trials is not fixed but randomly drawn from a beta distribution. It can account
for both sampling and epigenetic variability. The beta-binomial model is used by methylSig
(Park et al., 2014) and others for site level differential methylation detection.
Different from the count-based data obtained from BS-seq, DNA methylation arrays
provide fluorescence intensities that are quantified as the relative level of methylated and
unmethylated probes. Specifically, two types of data are used for downstream analyses.
The yS-value is an estimate of the methylation level using the ratio of intensities between
methylated and unmethylated alleles. They range between 0 and 1. Ideally, a value of 0
indicates that all copies of the CpG site in the sample were completely unmethylated, and
a value of 1 indicates that every copy of the site was methylated. The yS-value is defined
below:
ma x(Methylated, 0)
m ax(M ethy lated, 0) + ma x(Unmethylated, 0) + a "
The a in the denominator is used to stabilize the estimate when both the methylated and
unmethylated intensities are low. The a value is set to 100 by default. Note that after
correcting for background noise, the methylated and unmethylated intensities may have a
negative reading. To avoid this, max(Methylated, 0) and max(Unmethylated, 0) are used
to reset any negative values to 0 .
The other commonly used methylation measure is called an M-value. It is calculated
as the log2 ratio of the intensities of methylated probes versus unmethylated probes, as
defined below:

I max(Methylated, 0) + a \
2 \max(Unmeth ylated, 0) + a )
The a (by default equals 1) in the calculation is added in order to prevent unexpected large
changes due to small intensity estimation errors. M-values can range from negative infinity
to positive infinity. When the methylated and unmethylated probes have the same intensity
value, the M-value is 0. Positive M-values indicate more methylation is occurring than not.
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The a value in the calculations of both yS-value and M-value is typically negligible
due to the fact that more than 95% of CpG sites have intensities higher than 1000 (Du et al.,

2010) and thus it typically does not have a large impact on the calculated methylation level.
The relationship between the M- and yS-values can be expressed as:

M = log 2

1- S

( 1. 1)

Although the yS-values are useful for interpretation, there are some advantages to using the
M-values for statistical analysis, such as homogeneity of variance (Du et al., 2010). Also
M-values range from negative infinity to positive infinity, making it more suitable to use
statistical methods that have a normality assumption. Thus, M-values are recommended by
Du et al. (2010) for conducting differential methylation analysis.
Several statistical methods have been proposed for DNA methylation microarray
data to identify cytosine sites with significant differential methylation, including CpGassoc
(Barfield et al., 2012), MENT (Baek et al., 2013), IMA (Wang et al., 2012), and COHCAP
(Warden et al., 2013). The limma method (Smyth, 2004) is an approach first developed
for detecting differential expression in gene expression microarray data, but it can also be
used to test for differential methylation in DNA methylation microarray data. This method
is further described since it is used in downstream region level analysis employed in this
work. For DNA methylation studies, as well as other genomic studies like gene expression,
typically only a small number of biological replicates are available. However, the studies
are very complex, involving different aspects of biological processes and a large number
of variables. It is challenging to find statistically significant and precise features between
different conditions. The limma method (Smyth, 2004) tried to solve this problem by
fitting a linear model to the M-value of each genomic position, then using empirical Bayes
methods to estimate moderated t-test statistics. Global parameters are estimated using all
the variables at once, which enables the incorporation of correlated neighboring genomic
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features. The empirical Bayes approach is equivalent to shrinkage of the estimated sample
variances toward a pooled estimate. It borrows information between probes in order to
moderate the residual variances, and ensures that small sample inference can be conducted
with reliable and stable results (Ritchie et al., 2015).
1.5.2. Region Level Testing. While there are benefits of analyzing differential
methylation at the site level, there are reasons both biologically and statistically to test
differential methylation at the region level. It is shown that strong correlation exists between
CpG methylation levels over short distances. This correlation dissipates the further away
sites are from each other, such that it is no longer detectable at sites over 1000 bp apart
(Eckhardt et al., 2006). Differential methylation targets are most commonly clustered into
short regions. So it is meaningful to look at the differential methylation at a region level.
Also, when the difference in methylation is small and undetectable at the site level, the
persistence in small methylation differences over a region will provide a higher power for
detection.
1.5.2.1. Defining regions. There are two ways to define a region when performing
region level differential methylation testing. The first approach is to use predefined regions.
The density of probes on HM450 data varies across the genome, with higher coverage in
the promoter regions of genes and CpG islands (Illumina, 2012), as shown in Figure 1.3.
Some differential methylation region (DMR) detection methods, such as IMA, COHCAP
and QDMR (Zhang et al., 2011), concentrate on high density areas using predefined regions,
compromising only a subset of the HM450 probes. This approach may miss meaningful
clusters outside the predefined ones, but it can reduce the number of tests that need to be
accounted for when controlling the false discovery rate.
The second way to define regions is to use a post-hoc aggregation method based on
the data. After conducting the initial analysis on each cytosine site, probes are included in
a region if they have significant site level differential methylation and are within a certain
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Figure 1.3. HumanMethylation450 BeadChip coverage of different regions. Figure from
Illumina (2012).

distance of other significant sites. Bumphunter (Jaffe et al., 2012) and DMRcate (Peters
et al., 2015) both use this approach to define a region. These methods are described in more
details below since they will be utilized in this work.
I.5.2.2. Testing methods. Many DMR testing methods have been developed, such
as Bumphunter, DMRcate and ProbeLasso (Butcher and Beck, 2015). In this study, Bum
phunter and DMRcate are used since they are the most commonly used statistical methods
for DMR detection in HM450 data. These methods are briefly described in this section
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and further details are provided in Chapter 2. Bumphunter is a data analysis pipeline de
veloped to identify DMRs associated with disease (Jaffe et al., 2012). A statistical model
is developed to take into account batch effects, which are a potential problem in large scale
and high throughput studies with many samples. Batch effects are the unnoticed correlation
between subgroups of samples which may be caused by experimental environments, such
as the temperature and humidity. First, a linear regression model regressing the methylation
value on the group status is applied to model differential methylation between the case and
the control groups at each CpG site. This model can also incorporate batch effects. The
slope coefficient corresponding to the group variable is then smoothed using loess. Clus
ters of consecutive probes for which coefficients higher than a predetermined threshold are
identified as candidate regions (bumps). Permutation tests, which permute sample labels to
create a null distribution of candidate regions, are then conducted to estimate the statistical
significance of the candidate DMRs.
DMRcate is a data-driven approach that can be used with WGBS data as well as
HM450 array data (Peters et al., 2015). First, a linear model is fit at each CpG site using the
limma method (Smyth, 2004). A Gaussian kernel with bandwidth A is used to smooth the
estimated test statistics. The Gaussian kernel is calculated with a standard deviation a = C,
where C is a scaling factor for the bandwidth. Smoothed test statistics are then modeled and
a p-value is calculated for each site. DMRs are defined by grouping the significant CpG
sites that are at most A nucleotides from each other.

1.6. MOTIVATION
Human genomes are complex and are regulated at multiple levels. Various types
of genomic data offer different aspects of complicated biological processes. Due to recent
advances in high-throughput technologies, multiple types of genomic data (e.g.

gene

expression, methylation, SNP) can be collected on the same individual. The Cancer Genome
Atlas (TCGA) is one of the most comprehensive cancer genomics programs. TCGA hosts
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a database with genomic sequence, expression, methylation, and copy number variation
data on over 11,000 individuals, with samples in over 30 different types of cancer. TCGA
is led by the National Cancer Institute (NCI) and the National Human Genome Research
Institute (NHGRI) to map genomic and epigenomic changes with the goal of accelerating
new discoveries in cancer-related research and to improve the prevention and treatment
of cancer (Wang et al., 2016). The International Cancer Genome Consortium (ICGC) is
another genomic data consortium, which provides data on genomic, transcriptomic and
epigenomic abnormalities, as well as somatic mutations in over 50 different cancer types
(Hudson et al., 2010).
Integrating and combining multiple types of genomic data can provide researchers
with deeper insights into complex biological processes and help scientists reveal disease
mechanisms for exploration, prevention and treatment. However, it is challenging to com
bine these different layers of information. This study focuses on the integration of DNA
methylation and SNP data to maximize the utilization of genomic information and improve
biologically meaningful discoveries. When analyzing DNA methylation data, SNP probes
are filtered out in a preprocessing step based on the population minor allele frequency and
their location relative to the target sites. Any potential SNP is filtered out for all individuals
due to the potential issues they pose for measuring methylation accurately. However, for
each individual, one may or may not have the specific allele associated with the SNP. When
SNP data are available, researchers can use the information to recover probes that are not
affecting the quality of the methylation array. For those probes that are actually influenced
by SNPs, imputation methods are proposed and investigated. Missing data are a common
issue in different areas, including biology, genomics, social sciences and financial studies.
Handling the missing value problem simply by deleting the missing instances can result in
losing useful information. Simple solutions such as replacing the missing value with the
mean may falsely lower the variability. This research will develop sophisticated imputa
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tion methods based on the specific data structure. The nature of DNA methylation data
and the correlation between neighboring sites will be considered when imputing missing
methylation values.
In this dissertation, imputation methods are proposed based on the characteristics
of DNA methylation data and these are described in Chapter 2. Predictive models built
under the regularized linear regression framework are used to impute the missing values.
The shrinkage approaches for the regression models include ridge, LASSO and elastic net.
Moreover, functional principal component analysis is applied to perform linear models as
an alternative imputation method. The proposed methods are evaluated and compared to
existing imputation methods via a simulation study and analysis of real data, described in
Chapter 3. The natural structure of the DNA methylation data is retained by using the real
data when conducting the simulation. Two types of DMRs are investigated to mimic the
methylation patterns in human genome. The performance of the imputation methods are
assessed in terms of imputation accuracy and DMR detection ability. Finally, in Chapter 4,
a summary of the work and discussion of future research is provided.
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2. DATA AND METHODS

2.1. DATA
2.1.1.

Data. In this research, Infinium HumanMethylation450 BeadChip (HM450)

DNA methylation data on breast cancer patients were obtained from The Cancer Genome
Atlas (TCGA) (TCGA, 2021). Measurements of methylation levels on 485,577 CpG sites
were given for the normal tissue and tumor tissue of 86 individuals. For 3 individuals,
methylation data were only available for the tumor tissue.

The raw data (provided in

.idat files) were downloaded using the DTT UI from National Institutes of Health, the
user interface (UI) design version of the Data Transfer Tool (DTT). Single-nucleotide
polymorphism (SNP) data on “Pathogenic Germline Variants in 10,389 Adult Cancers”
(Huang et al., 2018) were acquired from Genomic Data Commons (GDC). BCFtools (Li
et al., 2009), a tool to process binary variant call format (BCF) and variant call format
(VCF) files, was used to extract information on the 89 individuals for this study from the
compressed VCF file of the combined variant calls.
The methylation data were processed through the Chip Analysis Methylation Pipeline
(ChAMP) (Tian et al., 2017) in Bioconductor version 3.12 and R version 3.6.3. In addition
to the raw .idat files, a table stating the sample names and their treatment groups is also
required. The treatment group is acquired from the "Sample" code of each sample’s TCGA
barcode (Figure 2.1). In the code, ‘01’ indicates the tumor sample type and ‘11’ is the
normal sample type.
Prior to analyzing the DNA methylation data, several pre-processing steps are
needed. One of these steps involves filtering out probes for different reasons, as described
in Chapter 1. First, the data are filtered based on the detection p-values. Detection p-values
measure the likelihood that the total intensity of the probes is generated by a background
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Figure 2.1. The Cancer Genome Atlas (TCGA) barcode label explanation. Figure obtained
from (TCGA, 2011). ‘TSS’ is short for tissue source site.

distribution. If the detection p-value is below a specified significance level, it means the
observed value of total intensity is unlikely to be generated by the background noise, thus
the probe is considered detected (Heiss and Just, 2019). In this study, any probe with
detection p-values greater than 0.01 are filtered out (Hernandez-Vargas et al., 2010). The
percentage of problematic probes (based on the detection p-values) for each sample is also
monitored. When the proportion is above 0.1, the sample will be removed from the analysis.
Probes with less than three beads in at least 5% of samples per probe are also filtered out.
All non-CpG probes and multi-hit probes are removed due to potential cross-hybridization
and misinterpretation they may cause on methylation levels. In this research, the probes on
the sex chromosome are kept because all the samples are females. If the samples are from
both sexes, the probes located in chromosomes X and Y are suggested to be filtered out to
exclude possible sex bias (Ma et al., 2013). A normalization step is also required before
further analysis in order to adjust the bias caused by probe types and technical variation. In
this work, the peak-based correction (PBC) normalization (Dedeurwaerder et al., 2011) is
applied to the datasets before DMR detection.
Both a real dataset and a simulated dataset are used to study and evaluate proposed
imputation methods with respect to the potential SNP probes. To improve the computation
time without losing generality, in the real data analysis, a piece on the genome of a reasonable
length is considered for the analysis. A total of 7,987 probes with genomic locations between
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1 and 13,800,000 base pairs on Chromosome 1 is considered. In a typical analysis, the
probes with a potential SNP are also recommended to be filtered out based on the list
provided by Zhou et al. (2016). After performing the standard filtering criteria (including
potential SNP probes), 6,838 probes are remaining for analysis on this segment. This set of
probes is referred to as the incomplete dataset in the real data analysis.
The SNP filtering is based on the potential for an individual to have a SNP at a
particular location based on population data. However, many individuals will not have a
SNP but rather have the common variant in the population. In this research, SNP data are
integrated into the filtering phase and each sample is checked to determine if they actually
have a SNP or have the common variant at each potential location. This allows the recovery
of probes that do not have an actual polymorphism. By integrating the SNP data of all
the individuals into the filtering process, a dataset with the most information available is
generated. This is called the complete data, which contain 7,668 probes. After this step,
a list of DNA methylation probes that are actually affected by SNPs is obtained. These
probes can not be recovered since they actually contain true SNPs. Imputation methods are
developed to fill these positions in order to improve downstream analysis such as differential
methylation region (DMR) detection.
2.1.2. Characteristics of DNA Methylation Data. Methylation is not a random
process. Researchers have found that close neighboring CpG sites are likely to share the
same methylation status (Sun et al., 2019). That is, the DNA methylation level of a given
site is highly correlated with the methylation levels of neighboring probes. Neighboring
probes are defined in terns of their physical proximity based on their genomic location
on the chromosome (i.e., how far away in base pairs (bp) the sites are from each other).
This phenomenon could be due to the working distance range of DNA methyltransferase
(DNMT) in changing the methylation status of CpG sites (Jia et al., 2007). DNMT transfers
the methyl group to DNA and could methylate two CpGs within its working distance range
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in one binding event. The correlation may also be due to the influence of the nearby CpG
sites in the recruitment of DNA methyltransferase or demethylase enzymes (Lovkvist et al.,
2016). Demethylase enzymes remove the methyl group from methylated CpG sites.

Figure 2.2. Correlation between co-methylation and spatial distance in genomic base
pairs (bp). The methylation values represented by the orange dots are averaged over
25,000 individual measurements. Grey dots represent CpG methylation values based on
re-sampling of random CpG positions. Blue dots represent CpG methylation values based
on re-sampling of amplicons (obtained by PCR amplification). Correlation between CpG
methylation and spatial distance is not detectable at distances larger than 1,000 bp. Figure
from Eckhardt et al. (2006).

Eckhardt et al. (2006) mentioned that the methylation level of nearby probes have a
significant correlation over short (up to 1,000 bp) distances. As shown in Figure 2.2, the
correlation decreases rapidly at 1,000 bp and beyond. In the following statistical analysis
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steps, it is important to consider the genomic position of each probe and the potential of
neighboring correlation when performing model building, variable selection and missing
value imputation.

2.2. MISSING VALUE PROBLEM
Missing data can happen for many reasons that are beyond the control of the ex
perimenter. For example, missing data can arise due to technical errors, improper data
collection, respondents refusing to answer (e.g., in surveys) or participants that drop out.
For array based genomic technologies, missing values may be caused by image corruption
or low resolution (Troyanskaya et al., 2001). Missing values in DNA methylation are in
troduced due to various reasons, such as filtering out probes with low detection p-values
or low bead count, as well as removing multi-hit and non-CpG probes (Maksimovic et al.,
2012). One of the main sources of missing DNA methylation data is due to filtering out
SNP probes. Addressing this issue is the main focus of this work.
The missing data mechanisms are categorized into three classes by Rubin (1976).
If the probability of a missing value's occurrence is the same for all cases, and there is
no correlation between the missing and the observed data, the missing data are called
missing completely at random (MCAR). If the probability of being missing is the same
within a group of the data, then the missing data are called missing at random (MAR).
MAR means that there might be systematic differences between the missing and observed
data, but these differences can be explained by some observed variables. For example, in a
clinical trial studying blood pressure, some records are missing. People using manual blood
pressure monitors tend to not record their blood pressure reads, whereas the reads can easily
be recorded and stored for automatic digital blood pressure monitor users. The missing
percentage is different between people using different devices, but it can be explained by a
variable separating the two groups. Moreover, the variable is not related to the value that is
missing. A violation of the rule would be when people with higher blood pressure record
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their results but people with normal blood pressure don’t record as often. The missing
rate is related to the blood pressure values. This situation is the third type of missing data
mechanism, missing not at random (MNAR). Missing data are classified as MNAR when
there is a relationship between the tendency of a value to be missing and its value.
The underlying missing data mechanism has an impact on the choice and perfor
mance of different imputation methods. However, for real data, the missing mechanism
cannot be revealed by studying the data itself. In order to make reasonable assumptions,
knowledge of the data and the data collection process is required. Due to the randomness
of experimental and technological errors, MCAR/MAR is assumed for the HM450 data.
For example, the missing value is higher at the positions where probes fail to capture target
sequence, but the missing pattern is independent of the value itself (Lena et al., 2019a).

2.3. IMPUTATION METHODS
2.3.1.

Traditional Solution for Handling Missing Values. One of the most fre

quently used solutions for the missing value problem is listwise deletion. In this approach,
all cases with missing values will be omitted from an analysis. This default method is con
venient, but it reduces the sample size radically and can waste potentially useful information
present in the deleted entries. For example, an individual answering a survey many answer
only part of the questions and useful information may be contained in the subset of data that
is available for that subject. Also, when the missing pattern is not MCAR, listwise deletion
introduces large bias to the estimated mean (Little and Rubin, 2002).
Depending on the data type, there are several other convenient approaches to address
missing values. If the variable is quantitative, the missing data can be replaced by averaging
the non missing observations of the variable over all samples. If the missing value is quali
tative, the mode of the non-missing observations can be used. However, mean imputation
is problematic because it will shrink the standard deviation of the original distribution, and
disturb the relationship between variables (Van Buuren, 2018). For example, values that are
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imputed by a variable’s mean have almost no relationship with other variables. As a result,
the correlation between variables is biased toward zero, which is not wanted in data analysis.
In this research, the mean imputation method is applied on the missing methylation data
to provide a basis for comparison to a commonly used and easy approach. For each CpG
site, the missing values among the samples are replaced with the mean over the methylation
values of the non-missing samples of the same group for that site. As a result, if a CpG site
has more than one missing entry, they will have the same imputed value.
For longitudinal data, last observation carried forward (LOCF) and baseline ob
servation carried forward (BOCF) are widely used to address missing values, especially
in clinical trials. In the LOCF method, the value at the last time point prior to a subject
dropping out is used as the imputed value for all later time points in the study. Assumptions
of LOCF are strong, including the assumption that observations do not change when data
are missing and that a single data point can be used to estimate a distribution of potential
values (Molenberghs et al., 2014). BOCF instead uses the baseline value of an individual
as the imputed value for any missing data in the time sequence. It is suggested that the
effect of actual outcomes as well as the reason for the missing values should be investigated
before choosing this approach (Liu-Seifert et al., 2010).
2.3.2.

KNN Imputation. K-nearest neighbors (KNN) imputation was proposed by

Troyanskaya et al. (2001) to handle missing values in gene expression microarray data.
The gene expression data are arranged in a matrix with genes in the rows and samples or
experiments in the columns. For a gene with a missing expression value in sample i, K
other genes will be found, which have an expression value in sample i. The missing value
is estimated by a weighted average of the selected K gene expression values in sample i.
The weight is decided by the similarity of each gene to the gene with missing value. It
is found that the method is insensitive to the exact number of K within the range of 5-20.
Similarities are measured by calculating the Euclidean distance between two genes using
the rest of samples other than sample i.
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The idea of this method is applicable to DNA methylation imputation because it
uses the summary value from similar genes. With methylation data, the missing value is
estimated by a weighted average of methylation levels from K=10 CpG sites in the same
sample with the missing value. The KNN method will be applied in this work as one of the
comparison methods since it is a current approach in genomic literature. A drawback of
the KNN method is when the missing rate is very high at a particular CpG site, the method
fails when all the neighbors are missing in a particular position.
2.3.3.

MethyLImp. In 2019, Lena et al. proposed a linear regression model for

missing value imputation specifically for DNA methylation data. The idea aims to capture
the correlation between methyation levels of CpG sites by a linear regression model. The
missing values are imputed by iteratively performing linear regression on the available data.
The methylation data are organized in matrix form, with each methylation probe (CpG site)
being treated as a column variable and the rows correspond to each sample.
In the first step of methyLImp (Lena et al., 2019a), the first CpG site with missing
values is found. The method also searches for other CpG sites which have missing values
in the same samples as the first CpG site. The non-missing values for this site (or sites) are
denoted as Y i and the missing values as Y2. The imputation goal is to find the estimates
of Y2. Next, the cases with no missing value in the submatrix with only samples in Y 1
is denoted as X 1. X2 is the matrix whose entries include the same columns (sites) as X 1
and same rows (samples) as Y2. An illustration of how these matrices are defined can be
found in Figure 2.3. Any column (site) with missing values not included in Y 1 and Y2 are
not used in that specific imputation iteration. In this example, Y 1 is a two-column matrix
instead of a vector. The missing values in site 1 and site 6 will be imputed together because
samples with missing values are the same for those two sites.
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Figure 2.3. Example of the matrix definitions from the methyLImp method.

To address the limited range of the yS-values between 0 and 1, a logit function
l o g i t (p)

= log(y-p), p e [0,1] is applied on the Yj’s and the model is set up as:

l o g i t (Y)

= X • a + e.

(2.1)

Here Y corresponds to the Yi matrix, X is the Xi matrix, a are the regression coefficients
and e is the error term. The error term is assumed to be independently and identically
distributed with a normally distribution. The coefficients a of the regression model are
estimated by using the pseudo-inverse of X:

a =

X-1 • l o g i t (Y).

The pseudo-inverse X 1 is computed using the singular value decomposition (SVD) of X
(Golub and Reinsch, 1970).
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The SVD of an N x p matrix X is:

X = UDV'

where U is an N x p matrix and V a p x p matrix. U and V are orthogonal to each other.
D is a p x p diagonal matrix with entries d1 > d 2 > ... > d p , and the entries are called the
singular values of X.
Then, the Moore-Penrose pseudo-inverse (Penrose, 1955) has the form:

X-1 = VD-1U'

where D-1 is formed from D by taking the reciprocal of all the non-zero entries and leaving
the zeros as they are.
After obtaining &, the estimates of a , the missing methylation levels are predicted
as follows:
Y 2 = l o g i t -1(X 2 • a ).
In summary, the MethyLImp method uses X 1 and Y 1 to build a regression model and then
predicts the missing values in Y2 by fitting X2 in the model. An R-package implementing this
method called ‘methyLImp’ is available at GitHub (Lena et al., 2019b). Lena et al. (2019a)
compared methyLImp to existing methods including mean, KNN, SVDmiss (Fuentes et al.,
2006), softImpute (Mazumder et al., 2010), imputePCA (Husson and Josse, 2013) and
missForest (Stekhoven and Buhlmann, 2012). MethyLImp was shown to perform equally or
better than these methods and with good computational efficiency. The imputation methods
proposed in this work are compared to methyLImp since it is the primary imputation method
for DNA methylation data available.
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2.4. REGULARIZED LINEAR REGRESSION IMPUTATION
The number of CpG sites in DNA methylation data is much larger than the sample
size. For example, HM450 methylation data has over 450,000 probes but the sample size
in most studies is usually limited to around 100 individuals. When using a regression
model to impute missing values, this high dimensional problem is not negligible in the
models. A common problem of models with a large number of variables is multicollinearity.
Multicollinearity is the condition where two or more predictor variables in a statistical model
are linearly related (Dormann et al., 2013). The existence of multicollinearity can result
in increased variance of regression coefficients, which will lead to unstable estimation of
parameter values. For least squares regression, the regression coefficients a are estimated
as a = (X'X)-1X'Y, where X is the design matrix and Y is the response vector. When the
columns of the design matrix X are highly correlated, X'X is almost singular, leading to the
instability of a with small changes in the data.
Regularized linear regression imputation is proposed in this research to deal with
the issues posed by high dimensional data. The regularization approach involves adding a
constraint to the loss function. A loss function is used to penalize the prediction errors when
fitting the model (Hastie et al., 2009). For example, assume f is the function to predict Y
based on the input X . A convenient loss function is the squared error loss:

l = (Y - f (X))2.

(2.2)

Least square estimators are obtained by minimizing the squared error loss function. Regu
larization methods involve adding different penalty terms to the loss function, which prevent
coefficients from taking unreasonable values and help with the risk of overfitting. Three
different regularization methods (ridge regression, LASSO and elastic net) are explored in
this work for incorporation into the imputation process as described below.
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The imputation methods in this research iteratively evaluate the complete subset of
variables with missing entries. The iteration starts with the first CpG site measured on a
chromosome and works sequentially through the genomic locations. Here, the variables
are the methylation levels at different CpG sites. The input data is organized as each row
representing a sample and each column representing a probe for a particular CpG site as
shown in Figure 2.3. Several lists are generated: the list of all sample names S, all column
names C, and the names of columns with missing values V . The first step is to find the
variables with missing values V1 in V. Denote the list of row names of those missing
positions of V1 as SNA. Y i is the vector or data matrix with columns V1 and rows in S but
not in SNA. If the missing value positions are exactly the same for more than one variable,
Yi will be a matrix instead of a vector. X i is the submatrix with the same rows as Y i and
the columns in C but not in V . X2 is the submatrix with the samples in SNA and same
columns as in X 1. Finally, Y2 is the vector or submatrix of missing values at variables
V and samples in SNA. After obtaining Y 1, X 1, and X2 in the first iteration, methods are
applied to fit a generalized linear model with Y 1, X 1, and then predict Y2 by feeding X2 into
the fitted model. After the missing value(s) are imputed at variable(s) V1, the lists S, C, V
and SNA are updated accordingly. The algorithm will search for the next variable(s) with
missing values and the complete samples, and construct new vectors or matrices Y 1, X 1,
and X2. In this step, the imputed values for variable V1 will be treated as complete entries.
The iteration will stop when S and V are empty, meaning all the missing values have been
imputed.
This work is inspired by methyLImp to impute missing values in DNA methylation
data by utilizing a regression model. When forming the sub-matrices for imputation in
the previous steps, the number of variables is large compared to the number of samples
available, resulting in a high dimensional data problem. The proposed methods in this
research use regularization when fitting the model instead of using the pseudo-inverse of
the design matrix, which is not unique. To address the issues posed by high dimensional
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data, regularization (also known as shrinkage) approaches are used to shrink estimated
coefficients towards zero relative to the least squares estimates to reduce the variance and
help prevent overfitting (Hastie et al., 2009). Depending on the type of shrinkage approach,
some of the coefficients may be estimated to be exactly zero. In this work, the two bestknown regression regularization techniques (ridge regression (Hoerl and Kennard, 1970)
and the LASSO (Tibshirani, 1996)) are employed in the imputation step that involves fitting
a generalized linear model. An additional approach, the elastic net (Zou and Hastie, 2005),
is also explored that combines the ridge and LASSO methods.
2.4.1.
(1970).

Ridge Regression. Ridge regression was proposed by Hoerl and Kennard

By adding a small constant value A to the diagonal entries of X'X, the least

square estimator’s stability can be improved. The ridge regression estimator is a ridge =
(X'X + AIp)-1X'Y. Ridge regression shrinks the regression coefficients by imposing a
penalty on their size:

N
p
p
a ridge = arg m in { ^ (y i - ao - ^ xijaj)2 + A ^ a j }.
a
i=i
j=i
j=i

(2.3)

The first component in Equation 2.3, £ = (yi - a0 - Z p=1 xij a j )2, is typically called the
residual sum of squares or the Sum of Squares Error (SSE) and it represents the squared
error loss described previously. The second component of Equation 2.3, A Z p=1 a j , is
referred to as the penalty term, which performs the shrinkage of the coefficients. A > 0 is
the tuning parameter that controls the amount of shrinkage. The larger the value of A, the
more shrinkage towards zero is applied to the coefficients. Equation 2.3 can equivalently
be written as:

subject to 12 penalty

N
p
a ridge = arg min V (yi - ao - V xij aj )2
“
i=1
j =1

z
j =1

2£ '

a .

(2.4)
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with a one-to-one correspondence between A and t . This approach works via the trade-off
between bias and variance. A small bias is allowed in the coefficient estimates to reduce
the variance and make the estimates more stable.
The R package ‘glmnet’ is used to do the regularization by the cyclic coordinate
descent (CCD) method, which was developed by Friedman et al. (2010). To determine the
tuning parameter A, 100 values are generated. Two parameters are needed for the sequence
of A. The first one is the largest value for A such that all the coefficients are zero (denoted

Amax). Note that Amax =

m for ridge regression, so a value is picked corresponding to the

coefficients close to zero. The second one is a pre-determined ratio of the smallest value of
the generated A sequence to Amax. When the number of samples is greater than the number
of probes in the model, the ratio is set to be 0.0001. In this study, the number of probes is
greater than the number of samples, thus the ratio is set to be 0.01 to increase the penalty
for complexity. Amin is obtained by Amin =0.01 • Amax. The ten-fold validation error for each
A value is computed. The tuning parameter with the smallest cross-validation error is used
to fit the model for each iteration.
2.4.2.

LASSO Regression. The least absolute shrinkage and selection operator

(LASSO) was proposed by Tibshirani (1996), which is an l1 penalized least squares method
for linear models. The residual sum of squares (SSE) is minimized with a constraint that
the sum of the absolute values of the coefficients is less than a constant. This approach is
similar to ridge regression, but the use of the l1 penalty instead of the l2 penalty can force
certain coefficients to be zero. This is different from ridge regression which never sets the
value of coefficients to be exactly zero. Ridge regression can be challenging for model
interpretation, whereas LASSO yields a sparse model that results in variable selection by
identifying the predictors with non-zero coefficients.
The LASSO estimate is defined by:

N
p
p
a LASSO = a r g m in { ^ ( y - ao - ^ xij aj )2 + A ^ | aj |},
a
i=i
j=i
j=i

(2.5)
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where A is the parameter that controls the shrinkage. Equation 2.5 can also be written as:

N
p
a LASSO _ arg min V (y - ao - V Xij aj )2
a
i_i
j_i

(2.6)

subject to l1 penalty

aj \< t
with a one-to-one correspondence between A and t . This makes the solutions nonlinear in yi
and there is no closed form expression as in ridge regression, so the minimization problem
needs to be solved analytically. Efficient algorithms have been developed to compute the
estimates of LASSO, such as the least angle regression algorithm (Efron et al., 2004). The
same tuning procedures are adopted from ridge regression to choose the optimal value for
A with ten-fold cross validation from a sequence of 100 generated A values. To generate the
100 values, Amax is selected to be the value that makes all the coefficients zero.
To visualize differences in estimation for LASSO and ridge regression, consider the
simple case when there are two variables with corresponding coefficients a 1 and a2. LASSO
has the constraint function | a 1 | + | a 2 \< t . This implies that LASSO coefficients have
the smallest loss function for all points that lie within the square, given by \ a 1 \ + \ a 2 \< t .
Ridge regression has the constraint function ®2 +

< t . Figure 2.4 shows the shape of the

constraint regions for LASSO (square) and ridge regression (circle), along with the contours
of the residual sum of squares. If the sum of squares hits one of the corners of the square,
then the coefficient corresponding to the axis is shrunk to zero.
If some of the probes have no correlation with the true methylation levels at the
specified sites, LASSO outperforms ridge regression by shrinking the coefficients of those
probes to zero.

One limitation of LASSO occurs when there are two or more highly

correlated sites and LASSO randomly selects one of them. In methylation data, multiple
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Figure 2.4. Estimation picture for LASSO (left) and ridge regression (right). The green
areas are the constraint functions and the red curves are the contours for the least squares
error functions. Figure modified from (Hastie et al., 2009).

CpG sites work together on a biological process and the correlation among them should be
high. LASSO will only pick one site in the same group, making the model less interpretable
by researchers since potentially important sites are filtered out.
2.4.3. Elastic Net Regression. A compromise between ridge and LASSO was
proposed by Zou and Hastie (2005) as the elastic net penalty. The elastic net estimate is:

N
p
p
a enet = arg min { ^ ( y - ®o - ^ Xijaj )2 + A ^ (0i | aj | +O2a j )}
a
i=i
j=i
j=i
where

01 + 02 = 1.

(2.7)
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Figure 2.5. Comparison of the constraint functions for ridge, LASSO and elastic net
regression. The solid red line represents elastic net regression when 61 = 02 = 0.5. Figure
from Zou and Hastie (2005).

The l1 penalty part of the elastic net generates a sparse model and the l2 penalty part
removes the limitation of LASSO that can only select a limited number of variables. Thus,
important variables that work together can be included in the model together. Moreover, it
stabilizes the li regularization path. Compare the matrix form of the elastic net estimator:

&enet = argm in a'(
a

— 2 )a - 2y'Xa + A1 | a | 1
1 + A2

(2.8)

and the lasso estimator:

a LASSO = argmin a'(X'X)a - 2y 'X a + A1 | a | 1
a

(2.9)
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where J 1, J 2 are two fixed non-negative numbers. Note that Q1 = j j r ^ and 02 = jj+j ^.
D e n o te 2 = X'X, which is the sample version of the correlation matrix 2. Notice the
following term in Equation 2.8:
X'X + J2I
1+ J

= (1 - r ) 2 + yi

where y = J 2/( 1 + J 2) shrinks 2 towards the identity matrix I. Equations 2.8 and 2.9 show
that the elastic net penalization is equivalent to replacing 2 with its shrunk version in the
LASSO.
A mixing parameter determines the type of penalty for regularization. As shown
in Figure 2.5, the elastic net penalty is a mixture of the ridge and LASSO penalties. The
mixing parameter is zero for ridge regression, one for LASSO regression and can vary
between 0 to 1 for elastic net regression. In this research, the elastic net regularization
method with the mixing parameters 0.2, 0.5 and 0.8 are explored. The same procedures
to select the tuning parameter (J) are adopted from ridge regression. The optimal value
for J is chosen using ten-fold cross validation from a sequence of 100 generated J values
generated.
2.4.4.

Summary. In this research, linear regression with regularized methods are

proposed as imputation methods for missing DNA methylation data. As mentioned earlier in
Section 2.4, for each CpG site with missing values, Y 2 is imputed by generating predictions
from applying X 2 to model that was fit using X i and Y i. An improvement on imputation
performance over methyLImp in terms of imputation accuracy is expected for the proposed
methods because the potential problems caused by the nature of genomic data, such as high
dimensionality and multicollinearity, are addressed. However, the computational efficiency
is a challenge for the proposed methods because a ten-fold cross validation is required for
parameter tuning for each iteration when fitting the model with Y i and a high dimensional
X i. Section 2.5 describes the proposed solutions to handle this issue.
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2.5. REGULARIZED REGRESSION WITH VARIABLE SCREENING
In the linear model set up shown in Figure 2.3, the response variable Y i can be
a matrix when the missing value positions are the same in more than one variable. The
imputation will be performed using the same group of variables X 1 for all the columns in
Y 1. However, in reality the variables in the submatrix Y 1 are typically uncorrelated. Here
a method to impute them individually instead of altogether is proposed. Additionally, the
submatrices X 1 and X2 involve thousands of variables, which make the computation cost
very high. To solve this problem, an extra step is added in each iteration of the imputation
process. After the formation of Y 1, X 1 and X2 (note here Y 1 is always a vector), the
dimensions of X 1 and X2 are reduced to the length of Y 1 (i.e., the number of samples) to
get X i and X2. The selection is based on the Pearson correlation between the predictors
and the response. Then, the regularization methods proposed in the previous section (ridge
regression, LASSO, and elastic net regression) are applied to Y 1 , X 1 and X 2 to obtain
imputed values for Y2. The steps for each imputation iteration are summarized below:
1. Matrices Y 1, X 1 and X2 are formed according to the description in Section 2.4 and
Figure 2.3. Here, Y 1 is a vector since each variable is imputed separately.
2. X 1 and X 2 are obtained by reducing the dimensions of X1 and X2 to the length of Y 1
(i.e., the number of samples) using the Pearson correlation as a selection criteria.
3. A regularized linear regression model is fit using Y 1 and X 1.
4. Y2 is predicted using X 2 and the model in the previous step.
After each iteration, the algorithm will move to the next CpG site with missing value(s) and
repeat the steps above until all missing entries are imputed.
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2.6. FUNCTIONAL DATA ANALYSIS IMPUTATION
The methylation level of each probe is dependent on the neighboring probes as
described in Section 2.1.2. The methylation level values can be viewed as a curve over the
genome. However, the previously described approaches do not incorporate this inherent
ordering with neighboring dependency directly into the methodology. In this section, a
functional data approach is proposed for imputation to address these issues. The basic
concepts of functional data analysis (FDA) are introduced before proposing the functional
principal component analysis (FPCA) imputation method.
The DNA methylation measurements for each sample can be treated as one single
observation with underlying structure, rather than multiple observations of independent
variables. The key assumption of functional data analysis is that there exists a function

X to represent the intrinsic structure of the data and the function is smooth. This can be
expressed as:

Yij = Xi (tij) + €i,j

(2.10)

where Yj represents the observed methylation level of individual i at the genomic location

tij (i.e., CpG site), Xi(tij ) are the smooth functional data and ei,j is the error that account
for "roughness" in the raw data. Here, i is the individual sample (i = 1 , . . . , n) and j is the
genomic location (j = 1 , . . . , ni).
2.6.1.

Basis Function. To approximate the data as a function, a basis function

system is needed. A system of basis functions is a set of known functions, denoted as p k
that are independent of each other. Let k = 1,2 ,3 ,..., K where K is the total number of
basis functions. A linear combination of the basis functions constructs the desired function
of the data as follows:

K
X (t ) = ^ ck pk (t )
k=1

(2 . 11)
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where ck are the coefficients corresponding to the basis functions 0 k. Some common
basis functions include the monomial system (1, t, t 2, t3,...), the Fourier series system
(1, sin(mt), cos(mt), sin(2mt), cos(2mt), sin(3mt), cos(3mt),...) , and the exponential basis
system (e^1t, e^2t, eX3t, . . .) (Ramsay and Silverman, 2007).
2.6.1.1.

Fourier series. For periodic data, the Fourier series basis functions are

commonly used, since the trigonometric sin and cos functions are periodic. Suppose the
function repeats itself over a time period T, and let m = 2 n /T . The Fourier series basis
functions are defined as follows:

0 1(t) = 1
0 2(t) = sin(mt)

<p3(t ) = cos(mt)
<p4(t ) = sin(2mt)
(2.12)

05 (t) = cos(2mt)
0 6(t) = sin(3mt)

0 K(t) = cos(mmt).
The total number of basis functions is K where K = 2m + 1. Fourier series have traditionally
been used as basis functions in the past due to their computational efficiency. The Fourier
basis is useful for extremely stable functions and ideally for data with some degree of
periodicity (Ramsay and Silverman, 2007). However, this basis is not appropriate for data
with discontinuities in the function or in low order derivatives of the function.
2.6.I.2.

Splines. Often, non-periodic functions are approximated by spline func

tions. Especially for data involving a large number of observations, spline function basis
systems have been developed. Splines are polynomial segments joined end-to-end, but the
segments are constrained to be smooth at the joining points. The joining points are called
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knots. The order m of the polynomial is the number of its highest power (degree) plus one.
Being smooth at the breakpoints means the function values should be equal at these points.
Further, the derivatives up to order m - 2 are also required be the same at the breakpoints.
The spline function is determined by the order m of the polynomial segments and the knot
sequence t1 where l = 1 , . . . , L - 1. The number of parameters needed is m + L - 1.
The B-spline basis system is the most popular spline system. It was developed
by De Boor (2001). The B-spline basis system has the following properties: (1) Each
basis function is a spline function defined by m and

t

, (2) any linear combination of the

basis functions is a spline function, and (3) any spline function defined by m and

t

can be

expressed as a linear combination of these basis functions in the system. This system also
has a compact support property, which states that a B-spline basis of order m is positive
over no more than m intervals, and these intervals are adjacent. This property makes splines
also computationally efficient.
2.6.2.

Roughness Penalty. The coefficients of the B-spline functions can be deter

mined by least squares estimation. Consider the error sum of squares (SSE):
n
SSE = J ] ( y j - X(tj ))2.
j =1

(2.13)

Here the notation for the i index is removed for simplicity. To ensure the fitted curve is
smooth, a simple linear smoother is obtained by finding the ck’s that minimize the following
least squares criteria:
n

K

^ [ y j - Y j ck<Pk(tj )]2.
j=1
k=1

(2.14)

The method is suitable under assumptions that 6j ’s in model 2.10 are independently and
identically distributed with mean zero and constant variance.
Fitting the data and the smoothness of the curve are two competing desires. The
least squares approach can be modified to incorporate a roughness penalty to address this
issue. Roughness penalty methods for smoothing work by optimizing a fitting criterion
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by penalizing the roughness of the curvature. The curvature of a function at t can be
characterized by the square of the second derivative (D2X (t))2. The roughness of a function
can thus be defined as the integral of this value ^ (D 2X(t)) 2dt. A parameter A is used to
control the roughness by minimizing the penalized squared error (PENSSE) (Ramsay and
Silverman, 2007):

PE NS SE a (X) =

[(yj - X(tj )]2 + A J (D2X(t))2dt

(2.15)

where D X (t) is the slope of X (t), D 2X (t) = dLX(t) is the second derivative of X (t) and
thus represents its curvature. A is a smoothing parameter measuring compromise between
fit and smoothness. As A increases, the roughness will be penalized more and X (t) will
become linear. As A decreases, the penalty is reduced and X(t) will fit the data better. The
Smoothing Spline Theorem (Ramsay and Silverman, 2007) states that the function X (t) that
minimizes PE NS SE A(X ) is a spline function of order 4 with a knot at each sample point tj .
Therefore, unequal spacing of the sampling points is not a problem, since smoothing splines
automatically take care of high density areas in the data and areas with fewer observations.
2.6.3.

Functional Principal Component Analysis Imputation. Principal compo

nent analysis (PCA) (Jolliffe, 2002) is a dimension reduction tool for multivariate data.
Principal components are a new set of variables where each component is a linear combina
tion of the original variables. The weights in the first components are chosen to maximize
variance. Each subsequent component maximizes remaining variation and is orthogonal to
all other components. The principal components are computed and then used for a change of
basis on the data. This allows the dominant modes of variation in the data to be represented
in a small subset of components. Most of the time, the first few principal components are
enough to explain the majority of the variability in the data, and the remaining principal
components will be discarded, resulting in dimension reduction in the data. For an n x p data
matrix X , each column is a vector of observations on one variable. A linear combination a
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of the columns of matrix X: £ p=1 ajXj = X a is aimed to achieve maximum variance, where

Var (X a) = a'Sa and S is the covariance matrix. With the restriction a'a = 1, maximizing
a'Sa provides the solution that a is a unit norm eigenvector of the covariance matrix S,
with corresponding eigenvalue X’s. The covariance matrix S is a p x p real symmetric
matrix, and thus should have exactly p real eigenvalues. The eigenvectors are defined to be
orthonormal, such that ajaj * = 1 when j = j * and 0 otherwise. This ensures each set of
linear combination is uncorrelated. By using the top k largest eigenvalues, the data could be
represented with most of the variance explained. X ak are called the principal components,
the eigenvectors ak are called the principal component loadings.
PCA was extended to functional data and became widely used in functional data
analysis to capture the dominant modes of variation in the smoothed curves. Functional
principal component analysis (FPCA) converts infinite-dimensional functional data to a
finite-dimensional vector of random scores.

The underlying stochastic process can be

represented by a finite sequence of uncorrelated random variables. These variables are
called the functional principal component scores (FPC scores). Similar to PCA, usually
only a finite subset of the sequence is used that captures most of the variation.
The following formulation illustrates how FPCA can be formulated in terms of
DNA methylation data and used for imputation. Assume that the methylation levels across a
chromosome have the pattern of function X , and X has an unknown smooth mean function
p

(t) and a covariance function which is defined as:

cov(X (s )), X (t)) = G(s , t)

(2.16)

where s, t e T, and T is the genomic location. G(s, t) can be expanded with the orthogonal
expansion:

TO
G(s, t) = ^ X kp k (s)(pk (t )
k=1

(2.17)
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where Xk is the set of eigenvalues and p k are the corresponding eigenfunctions that form an
orthonormal basis set with a unit norm in l2. The underlying pattern for the ith sample can
be expressed as:

TO

Xi(t ) = y.(t) + ^ Qkpk(t )
k=l

(2.18)

where p k is the kth eigenfunction, and

cik = J ( X i ( t ) - M t))pk(t)dt

(2.19)

is a coefficient projecting (Xi - n ) in the direction of p k.
The data Yi(tij ) is the j th observation of the random function Xi (•) at a random
genomic location tij , also denoted as Yj, which can be represented as:
TO

Yi(tij) = Xi(tij ) + 6ij = ^ (tij ) + ^ ^ cikp k(tij) + p / .
k=l

(2.20)

Here eij represents the measurement random errors of the ith sample at j th genomic location,
and are assumed to be independent and identically distributed with mean 0 and variance

a 2. From Equations 2.19 and 2.20, it can be shown that:

Yi (t )

(Xi (t) - ju(t))pk(t)dtpk(t ) + 6.

(2 .21)

The infinite series in Equation 2.18 can be truncated by L such that the first L components
explains at least tx x 100% of the total variance, that is:

y

l

x

L = min{L > 1 :

> t x}

(2.22)

Z,k=i Xk
where M is the largest number of components with Xk > 0 and t x is a user defined threshold
between 0 and 1. When the observations Y (tij) are missing for some j , the missing entries
can be imputed by the predicted values Xi(t ).
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To estimate X (t ), the estimated values of l (t ), c j and $ k ( t ) are needed. To find the
estimates of the eigenfunctions <p and eigenvalues X, the eigenequation can be expressed as:

G <p = X(p.

(2.23)

The estimate of G is obtained by smoothing the empirical covariances (Yao et al., 2005).
Then the eigen-decomposition procedure is applied to the covariance function estimate to
get the estimated eigenvalues Xj and eigenfunctions <pk (t ).
The estimate of cik cannot be calculated easily through the approximation of Equa
tion 2.19 because if the number of repeated observations is small or if there are missing
positions, the integral is not accurate. Also the true Xi(t ) cannot be observed. The observa
tions are Yi (tij ) = Xi (tij ) + eij and bias will be introduced if Xi is replaced by Yi . An approach
first proposed by Yao et al. (2005) provides a solution to these issues of estimating the cik 's.
The eigenfunction basis is estimated from the data, and functional principal component
score estimates are obtained by a conditioning step. The assumption is that the functional
principal component scores cik and the error term q j are jointly Gaussian. The conditional
functional principal component scores are:

E ( cik | Yi) = Xk$'ikE y ; (Yi -

)

(2.24)

where Xk is the k th eigenvalue, Yi = [Y (tii),. . . , Y ( tin)]', V i = [l i ( to ) , . . . , l i ( tim )]', Q ik =
[<pk ( tii ) , . . . , (pk ( tim)]/,

and S Yi is the covariance matrix of Y i , with dimension m x m . The

^Y; is represented as:

E y ; = cov( Y i, Y i) = cov( X i, X i) + a 2\ n

In scalar form this is:

(2.25)
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(£ y ,.)j,i = G(tij, tii) +

$ji

(2.26)

with 6jl = 1 if j = i and 0 if j ^ i .
The estimated scores in Equation 2.24 are obtained by:

(2.27)

ci,k = 4 ^ \ kt y1(Yi - &i)

where & = [& (tn),. . . , fit (tin.)]' is the estimate of

^

= [$k (til),. . . , $k (tm )]' is the

estimate of 0 ik and t Yi is the estimate of t Yi. The estimated score Q,k will be used as the
functional covariates to perform functional linear regression with a scalar response.
2.6.4. Functional Linear Models. In traditional linear regression models, the de
pendent variable and the independent variables are scalars. One way to set up a functional
linear model is with a scalar dependent variable yi , but replace the independent variables
by a function x (t):
yi = ao + J xi(t)a(t)dt + q-.

(2.28)

One functional linear regression approach is to regress Y on the principal component
scores as functional covariates (Ramsay and Silverman, 2007), and it will be referred to as
Functional Principal Component Regression (FPCR) in this dissertation. A subset of the
100 nearest available probes to the probe with missing values is utilized in the modeling to
capture a relevant set of neighboring probes. Y i is an n l x 1 vector of the samples with
complete entries for the probes with missing values. Y2 is an n2 x 1 vector and it represents
the missing entries that need to be imputed. X2 is the n2 x 100 matrix with data on the 100
neighboring probes with complete data and with the same rows of Y2. X 1 is an n 1 x 100
matrix sharing the same rows with Y 1 and the same columns with X2.
The R package ’fdapace’ is used to find the principal component scores via the
Principal Analysis by Conditional Estimation (PACE) algorithm (Yao et al., 2005). The
first step is to estimate the mean function ^ as in Equation 2.18 based on the pooled data of
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all individuals

Xi

, with local linear smoothers (Fan and Gijbels, 1996) for function and
X2
surface estimation. A one-curve-leave-out cross-validation is used to choose the smoothing

parameter. The conditional expectation method is then used to estimate the FPC scores.
Finally, the response Y 1 is regressed on the functional principal component scores to build
the functional linear model. The model is then used to predict Y2. After each iteration, the
algorithm will search for the next CpG site with missing value(s). The process of FPCR
model fitting and prediction will be repeated. Imputation is completed when there is no
missing value remaining in the dataset.

2.7. DMR DETECTION
The proposed imputation methods based on regularized regression and FPCR will
be compared with mean imputation, KNN imputation, as well as the methyLImp method.
To evaluate these methods, imputation accuracy is important since it represents how close
the imputed values are to the real values. However, the goal of imputation is to obtain
statistically valid results from the incomplete data. Thus, the quality of the imputation
should also be evaluated with respect to this ultimate goal of DMR detection. A simulation
study will be conducted to evaluate the imputation accuracy, and more importantly, the
influence of imputation on DMR detection. Bumphunter and DMRcate are commonly
used methods for DMR detection that are used in this work to evaluate the imputation
performance on DMR detection. An overview of these methods is provided below.
2.7.1.

Bumphunter. The Bumphunter method implemented in the Bioconductor

package ‘ChAMP’ is used to find DMRs. The statistical model used by Bumphunter is:

Yij =

)+

p
q
)Xi + ^ j Tk(tj) Zi,k + ^ ^ai,jWi,l + Ei,j
k=1
l=1

(2.29)
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where Yj is the epigenomic measurement at the j th genomic locus for individual i, tj
denotes the location on the genome of the j th locus, ^(tj ) is the baseline level of epigenomic
measurement, Xi is the condition of interest, J3(tj) measures the association between Xi and
the epigenomic measurement Yij at location tj, Z ’s are potential measured confounders (e.g.
sex, age, race), each column of Z represents a different confounder, y k(tj ) is the effects of
confounder k at locus tj, W represents potential unmeasured confounders or batch effects
(e.g. temperature, humidity), ai,j is the effect of the unmeasured confounder l on locus tj,
and ei,j is the unexplained variability.
In the Bumphunter analysis pipeine, the linear regression model 2.29 is fit by
regressing the methylation value Yj on the group Xi to model differential methylation
between the case and the control groups at each CpG site. The slope (3(tj) is then smoothed
using the loess method with a smoothing window ranging from 300 to 900 base pairs
to get the smoothed fi(t ).

For most genomic positions, the J3’s are zero because the

methylation levels at these positions are not significantly different between groups. Each
point is weighted based on the standard error obtained from the linear model. The smoother
works well to reduce the effect of outliers. Clusters of consecutive probes for which all
the smoothed fi(t ) values that are greater than a predetermined threshold are identified
as candidate regions (bumps) Rn, n = 1 , .. ., N . The maximum gap is a user determined
distance. When neighboring probes are less than that distance, they will be included in one
region. Next, clusters are defined using the following criteria: 1) the cluster has at least 4
probes, and 2) the probes inside one cluster are all less than or equal to 500 base pairs. The
99th percentile of the slope estimates is used as a cutoff to determine the candidate regions.
This means the values of the estimate of the methylation profile above the cutoff or below
the negated cutoff are treated as candidate regions.
Permutation tests, which permute sample labels to create the null distribution of
candidate regions Rn, n = 1, . . . , N , are then conducted to estimate the statistical significance
of the candidate regions. The regions that are produced in the permutations are considered
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null regions and can provide a null distribution for Rn . This method can solve the problem
of correlated measurement errors, batch effects and so on. The number of resamples is
set to be 10. Each of the 10 permutations will generate an estimated null distribution.
The p-value is the percent of candidate regions obtained from the permutations that are as
extreme as the observed region. False discovery rates (FDR) are calculated based on the
p-values, and Q-value is defined as the minimum FDR at which the associated area may
be called significant. The family-wise error rate (FWER) is also calculated, which is the
proportion of permutations that had at least one region as extreme as the observed region.
2.7.2.

DMRcate. The Bioconductor package ‘DMRcate’ is also used to find DMRs.

At each CpG site, a linear model is fit using the limma (Smyth, 2004) method. The square of
the t statistic Y = tj is used as the local statistic at each site i. The use of the squared t statistic
allows the method to obtain the magnitude between methylation levels of two groups instead
the direction of effect. Gaussian smoothing is then applied to the test statistics using a given
bandwidth A. Next, suppose there are n CpG sites on a chromosome; x\ < x2 < ••• < xn
representing all the locations. A Gaussian smoother is used to smooth the Yi at locations
xi for each chromosome. The Gaussian kernel weights are Kij = exp | [xj a jj] j , where

a is the kernel scale factor, a = A /C . The value for the bandwidth A is set to be 500.
As mentioned in Section 2.1.2, the correlation on methylation levels between sites over
longer distances is not noticable. C is also user defined, and is set to be 5. Smoothed test
statistics are then modeled using the method of Satterthwaite (Satterthwaite, 1946), and a
p-value is calculated for each site. Significant sites are reported after Benjamini-Hochberg
adjustments on p-values. Finally, DMRs are defined by grouping the significant CpG sites
that are at most A nucleotides from each other.
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3. RESULTS

3.1. OVERVIEW
In this chapter, an analysis based on real data as well as a simulation study are
presented to evaluate the performance of the imputation methods proposed in this work
compared to the existing methods. The DNA methylation data described in Section 2.1.1
are utilized both for the real data analysis and to guide settings in the simulation study.
The set-up of the simulation study is first described, followed by a discussion of how the
imputation methods will be evaluated in both the real and simulated data. Results are then
given for the real data followed by results for the simulation study.
Three existing methods (mean, KNN, methyLImp) are compared to the proposed
methods on imputation accuracy and ability to detect true differentially methylated regions
(DMRs). A total of 11 proposed methods are compared, which can be categorized into
three groups. The first group includes the regularized methods: ridge regression (Ridge),
LASSO, elastic net with 0.2 mixing parameter (elastic net 0.2), elastic net with 0.5 mixing
parameter (elastic net 0.5), and elastic net with 0.8 mixing parameter (elastic net 0.8).
The second group includes all of these regularized methods with variable screening and
imputation on a site by site basis (1 by 1) rather than altogether. These methods are denoted
the same as above with 1by1 at the end: Ridge 1by1, LASSO 1by1, elastic net 0.2 1by1,
elastic net 0.5 1by1, and elastic net 0.8 1by1. The final alternative approach evaluated is
the functional principal component regression (FPCR) method.
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3.2. SIMULATION STUDY
The purpose of the simulation study is to investigate the performance of the pro
posed imputation methods on imputation accuracy and the ability to detect differentially
methylated regions. It is important to simulate the data in a way that preserves properties
of real methylation data. The HM450 dataset described in Section 2.1.1 is utilized to help
create a simulated dataset with a realistic structure. The distribution of the HM450 probes
is related to the length of each chromosome. As shown in Figure 3.1, Chromosome 1 has
the most number of probes, Chromosome 6 has the second most number of probes and
Chromosome Y has the least number of probes. For computational efficiency, simulation
studies are performed on the 36,611 CpG probes located on the entire Chromosome 6 . The

86 Normal samples are preprocessed as previously described, resulting in 31,362 probes
after the filtering steps. This is recognized as the incomplete dataset. Among the filtered
probes, 5,076 probes are filtered out because of being potential SNPs. After integrating
the SNP data from “Pathogenic Germline Variants in 10,389 Adult Cancers” (Huang et al.,
2018), 4,917 probes are restored since SNPs were not present in any of the samples. This
provides the complete dataset with 36,279 probes. Thus, only 159 probes with true SNPs
are excluded.
The next step involves identifying a set of regions in which methylation differences
will be applied. To accomplish this, Adjacent Site Clustering (Sofer et al., 2013) is imple
mented to find region clusters on Chromosome 6 of the 86 Normal samples. The algorithm
merges a set of methylation sites wedged between two highly correlated CpG sites that are
located physically close to each other along a chromosome. More specifically, the criteria
is to merge two CpGs with Spearman correlation greater than 0.5 and are within 200 base
pairs into a cluster. This resulted in 2,478 clusters (14,801 probes total) with 4 or more
probes, among which 2,088 clusters contain 10 or fewer probes. 250 clusters are randomly
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Figure 3.1. The count of HM450 probes on each chromosome.

selected from the 2,088 clusters. It is found that 96 of these clusters have SNP probes that
could be restored from the 4,917 probes. A differential methylation effect is added to these
96 regions to evaluate the imputation techniques.
To ensure the nature of real data is well preserved, two key points are implemented
in the simulation steps. First, real datasets from the same group (Normal group) are used
as the base to add differential methylation effects. Moreover, the parameters used in the
simulation process are derived from summarized results of the real data analysis between
Tumor and Normal groups. The 86 Normal samples are randomly divided into two groups.
Before introducing differentially methylated regions (DMRs), the two groups are compared
using the DMR detection methods Bumphunter and DMRcate to make sure there is no DMR
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flagged. The yS-values are first converted to M-values using Equation 1.1. The M-values
are not bounded between 0 and 1, thus after adding the differential methylation effects, the
issue of out of limit values is avoided. An effect size of 1.5 is determined by comparing the
difference between Tumor and Normal groups of the real data.

Figure 3.2. Histogram of the sizes for all 96 clusters selected to be DMRs. The number
of probes in each cluster is marked on top of each bin. There are 46 clusters with 4 or 5
probes, and 8 clusters with more than 20 probes.

The details of the cluster size for all 96 clusters selected to be DMRs are shown
in Figure 3.2. It is a right skewed histogram, with more small clusters than large clusters.
There are 46 clusters with 4 or 5 probes, and 8 clusters with more than 20 probes. To ensure
the added treatment effects do not cancel out existing differences in M-values, for each CpG
probe in the methylation cluster, the group means of the two groups are first compared.
Treatment effects are then added to the group of probes with higher mean M-values.
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Previous studies have found that hyper- and hypomethylation can happen in the
same regulatory region with one followed immediately by the other (Day et al., 2013). The
methylation levels in the simulation are designed to mimic this situation in real data. For half
of the clusters, a type 1 simulation is applied by adding a treatment effect of 1.5 to M-values
of the probes with higher average M-values (Figure 3.3 a). In this case, values may be
added to different treatment groups inside a cluster. For the other half of the clusters, a type
2 simulation is applied as follows. The group mean of the M-values for each CpG probe
in each cluster is compared. For the group which has more probes with higher M-values,
a treatment effect of 1.5 is added to the M-values in the same group for the entire cluster
(Figure 3.3 b).

3.3. EVALUATION CRITERIA
3.3.1. Evaluation of Imputation Accuracy. In both the real and simulated datasets
a subset of the probes are randomly selected to be missing at different rates. It is important
to evaluate how accurate the imputed values are compared to the true values for the different
imputation methods. Performance of the imputation methods on accuracy are assessed by
using four different measures (Lena et al., 2019a). These measures are used to evaluate
imputation accuracy in both the real data and the simulated data imputation.
The imputed or predicted values are denoted as P, and the true values are denoted
as T . The Root Mean Square Error (RMSE) metric measures the square root of the average
squared difference between the predicted and the true values. It is the most widely used
metric for performance assessment of missing data imputation approaches and is given
below:

____________

RM SE (P, T ) =

Z?=i(Pi - Ti)2
n

(3.1)
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a. An example of type 1 simulation clusters
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Figure 3.3. Two types of simulation clusters. yS-values verses the genomic location are
shown here to illustrate the effects added. Black dots represent the Normal group and red
dots represent the Tumor group. The shaded areas are the differentially methylated clusters.
a, the effects are added to the probes with higher average methylation levels between two
groups. b, the effects are added to all the probes in a cluster.

The Mean Absolute Error (MAE) metric measures the average absolute difference between
the predicted and true values. It provides the average error to expect on the imputed value.
Note that by Jensen’s inequality, RMSE >MAE. The MAE is given below:

M A E (P, T ) =

Z?=1 \ P i - Ti |
n

(3.2)
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The Pearson Correlation Coefficient (PCC) metric measures the amount of linear correlation
between the predicted and true values. The PCC is given below:

PCC(P, T) =

Z U (P i - P)(T - T ))

V^n=i(Pi -

(3.3)

p )2Vz ?=1 (t - t )2

where P and T represent the mean value of P and T, respectively. The Mean Absolute
Percentage Error (MAPE) metric expresses the accuracy as percentage of error on the true
value. It gives an estimation of the error in terms of the magnitude of actual value. The
MAPE is given below:

M APE (P, T ) = 100 V
n
i
i=1

I Pi - Ti |
I Ti |

(3.4)

Note that smaller values of RMSE, MAE, and MAPE indicate greater accuracy; whereas
larger values of PCC are better.
3.3.2. Evaluation of DM R Detection. The goal of missing value imputation is to
improve the ability to detect differentially methylated regions that are important and biolog
ical meaningful. The simulation results will be compared with true DMRs to determine if
there are any improvements with respect to true positive, false positive, and false negative
regions. Note that true DMRs are unknown in the real data, so this evaluation is only con
ducted for the simulated data. A true positive (TP) DMR is defined as a significant DMR
declared by one of the detection methods (Bumphunter or DMRcate) that overlaps with a
region in which a treatment effect was added to the methylation M-values. The overlap type
is ‘any’, meaning any common genomic location between the compared regions will count
as them as overlapping. A false positive (FP) DMR is defined as a significant DMR declared
by one of the detection methods that does not overlap with any of the regions with added
treatment effects. A false negative (FN) DMR is defined as a region with added treatment
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Table 3.1. Details of probes filtered out by each step of the default filtering process.

Filtering Step
quality control probes
detection p-value
bead count
SNP
multi-hit
non-CpG

Probes Filtered Out
65
25,900
874
53,959
11
1,833

Remaining Probes
485,512
459,612
458,738
404,779
404,768
402,935

effect that does not overlap with any significant DMRs found by the detection methods. It is
possible that some true methylated regions are broken down into smaller regions for certain
DMR detection methods, or that more than one true region is recognized as one DMR.

3.4. RESULTS FO R REA L DATA ANALYSIS
3.4.1.

SNP Integration. Following the filtering steps in Section 2.1.1 for detection

p-values, bead counts, SNP probes, multi-hit probes and non-CpG probes, a total of 485,577
probes on the HM450 array are reduced to 402,935 probes. There are 65 built-in SNP
probes in HM450 array for the purpose of quality control, and they are typically removed
in preprocessing steps. The steps shown in Table 3.1 are sequential, meaning that each
filtering step is based on the filtering result of previous step(s). For example, if the probes
are filtered by bead count first, followed by detection p-value, the numbers in the second
column would be different.
By integrating the germline SNP data, a large portion of probes are restored. As
shown in Figure 3.4, 52,441 probes out of 53,959 (97.2%) are actually not SNP probes, thus
it is not necessary to filter them out. With the large portion of probes being restored, the
influence on DMR improvement is prominent. For the remaining 1,518 probes, imputation
methods are developed and evaluated on these probes that cannot be restored.
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Figure 3.4. Details of probe restoration by integrating SNP data.

As briefly discussed in chapter 2, the dataset used for real data analysis is described
below.

Starting with a section of Chromosome 1 (7,987 probes between the genomic

location 1 and 13,800,000), the filtering steps in Section 2.1.1 are conducted on the raw
intensity files (idat). This step results in a dataset with 6,838 probes, and this dataset is
noted as the incomplete data. After integrating the SNP data, 830 probes are restored. The
dataset with 7,668 probes is called the complete dataset. Missing values are introduced
in the 830 restored SNP probes at different missing rates. Imputation methods are then
conducted to obtain the imputed dataset.
The imputation accuracy is compared between the true values and the imputed
values. The DMR detection performance is evaluated using the complete dataset as a
standard since the true DMRs are unknown for the real data. The complete dataset is the
most informative since it utilizes the data from the most true probes possible for DMR
detection compared to the incomplete and imputed datasets. In the next section, simulated
data is used to assess the DMR detection improvements by imputation.
3.4.2. Im putation Accuracy. The performance of the imputation methods are
compared by computing the RMSE, MAE, PCC and MAPE for each method. The im
putation accuracy is assessed per CpG site. Three missing rates (20%, 50% and 70%)
are explored. The Normal group and Tumor group are separated when conducting the
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imputation. Overall, imputation methods perform better on the Normal group than Tumor
group, regardless of the detection method used or the missing rate. This likely due to the
heterogeneous nature of tumor samples. Additional discussion about this issue can be found
in Chapter 4.
Table 3.2 shows the performance with missing rate 20%. The performance of all
imputation methods work uniformly better in the Normal group than the Tumor group.
Take the mean imputation method as an example. The Tumor group has a RMSE of 0.116
while the Normal group has a RMSE of 0.085. While the mean imputation has the largest
RMSE in both groups, FPCR and KNN imputation perform only slightly better than mean
imputation in the Tumor group. In the Normal group, the regularized linear regression
imputation method using elastic net with mixing parameter 0.8 (elastic net 0 .8) has the
smallest RMSE, MAPE and the highest PCC. The methyLImp, elastic net 0.2, elastic net
0.8, LASSO 1 by 1, elastic net 0.2 1 by 1, elastic net 0.5 1 by 1 and elastic net 0.8 1 by 1
methods have the smallest MAE. In the Tumor group, the elastic net 0.2 1 by 1, elastic net
0.5 1 by 1 and elastic net 0.8 1 by 1 methods have the smallest RMSE, MAE and highest
PCC. The elastic net 0.8 method has the smallest MAPE, followed by all three of the elastic
net 1 by 1 methods.
Table 3.3 shows the performance of the imputation methods with missing rate 50%.
While the mean method is still the worst, the performance of the KNN method becomes the
next worst across all of the criteria in both groups. In the Normal group, all the regularized
methods outperform methyLImp in terms of RMSE, PCC and MAPE. The LASSO, elastic
net 0.2, elastic net 0.5, elastic net 0.8 and elastic net 0.2 1 by 1 methods have the lowest
RMSE and highest PCC. The methyLImp, LASSO 1 by 1, elastic net 0.2 1 by 1, elastic net
0.5 1 by 1 and elastic net 0.8 1 by 1 methods have the lowest MAE. The elastic net 0.2 1 by
1 method has the lowest MAPE. In the Tumor group, the elastic net 0.2 1 by 1 and elastic
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Table 3.2. Imputation accuracy for real data with 20% missing rate. The optimal value(s)
for each criteria are in bold.

N orm al

Tum or

mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1
mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1

RM SE

M AE

PC C

M APE

0.085
0.064
0.061
0.059
0.061
0.056
0.059
0.056
0.066
0.059
0.060
0.059
0.059
0.059
0.116
0.092
0.085
0.083
0.090
0.083
0.083
0.083
0.095
0.082
0.088
0.081
0.081
0.081

0.054
0.035
0.029
0.030
0.030
0.029
0.030
0.029
0.036
0.029
0.032
0.029
0.029
0.029
0.079
0.058
0.050
0.050
0.054
0.050
0.050
0.050
0.060
0.048
0.053
0.048
0.048
0.048

0.952
0.974
0.976
0.977
0.976
0.979
0.977
0.980
0.972
0.977
0.976
0.977
0.978
0.977
0.908
0.943
0.953
0.955
0.947
0.954
0.955
0.955
0.941
0.956
0.949
0.957
0.957
0.957

16.836
11.323
10.350
9.965
10.356
9.652
9.957
9.625
11.428
9.853
10.532
9.872
9.819
9.799
25.595
17.957
15.597
14.989
17.334
14.499
15.059
14.214
17.900
14.451
16.603
14.418
14.250
14.382

net 0.5 1 by 1 methods have the lowest RMSE. The elastic net 1 by 1 methods with mixing
parameter 0.2, 0.5 and 0.8 have the lowest MAE and highest PCC. The elastic net 0.2 1 by
1 method has the lowest MAPE.
Table 3.4 shows the performance of all imputation methods with missing rate 70%.
The KNN method performs the worst in terms of RMSE, MAE, PCC and MAPE. In the
Normal group, the elastic net 0.2, elastic net 0.5, Ridge 1 by 1 and elastic net 0.2 1 by 1
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Table 3.3. Imputation accuracy for real data with 50% missing rate. The optimal value(s)
for each criteria are in bold.

N orm al

Tum or

mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1
mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1

RM SE

M AE

PC C

M APE

0.084
0.067
0.062
0.058
0.059
0.058
0.058
0.058
0.064
0.059
0.059
0.058
0.059
0.059
0.118
0.111
0.090
0.088
0.095
0.089
0.088
0.088
0.097
0.087
0.091
0.086
0.086
0.087

0.053
0.038
0.030
0.031
0.031
0.031
0.031
0.031
0.036
0.030
0.032
0.030
0.030
0.030
0.080
0.065
0.054
0.053
0.058
0.054
0.053
0.053
0.061
0.052
0.055
0.051
0.051
0.051

0.953
0.971
0.975
0.978
0.977
0.978
0.978
0.978
0.973
0.977
0.977
0.978
0.977
0.977
0.906
0.919
0.946
0.949
0.940
0.948
0.949
0.949
0.937
0.950
0.945
0.951
0.951
0.951

16.742
11.664
11.469
10.495
10.725
10.513
10.485
10.484
11.078
9.855
10.327
9.752
9.789
9.821
24.784
18.411
16.255
15.661
17.477
16.032
15.771
15.797
17.907
15.264
16.592
15.182
15.177
15.219

methods have the lowest RMSE and highest PCC, The methyLImp method has the lowest
MAE. The lowest MAPE is obtained by elastic net 0.2 1 by 1 method. In the Tumor group,
the elastic net 0.2 1 by 1 method yields the lowest RMSE, MAE, MAPE and highest PCC.
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Table 3.4. Imputation accuracy for real data with 70% missing rate. The optimal value(s)
for each criteria are in bold.

N orm al

Tum or

3.4.3.

mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1
mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1

RM SE

M AE

PC C

M APE

0.085
0.108
0.063
0.063
0.063
0.062
0.062
0.063
0.066
0.064
0.062
0.062
0.063
0.064
0.118
0.127
0.095
0.097
0.101
0.096
0.096
0.096
0.100
0.096
0.095
0.093
0.094
0.095

0.054
0.059
0.032
0.034
0.034
0.034
0.034
0.034
0.037
0.033
0.034
0.033
0.033
0.033
0.080
0.080
0.057
0.059
0.062
0.059
0.059
0.059
0.062
0.057
0.058
0.055
0.056
0.056

0.952
0.923
0.974
0.974
0.974
0.975
0.975
0.974
0.972
0.973
0.975
0.975
0.974
0.973
0.905
0.893
0.941
0.938
0.933
0.939
0.940
0.939
0.935
0.939
0.940
0.943
0.941
0.941

16.657
25.502
10.593
11.086
11.131
10.925
10.923
10.920
11.554
10.725
11.013
10.540
10.578
10.680
24.745
22.801
17.799
17.774
18.846
18.043
17.664
17.642
18.215
17.040
17.626
16.688
16.812
16.917

DM R Detection. It is not possible to know the true regions that are differ

entially methylated between Tumor and Normal groups in the real data. Thus the complete
dataset described in Section 2.1.1 with the most information on hand is used as a standard
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for comparison. A potential false positive region is a region detected using the test data but
not detected with the complete dataset. A potential false negative region is a region found
by the complete dataset but not the test dataset.

Figure 3.5. Venn diagram of DMRs detected using incomplete, complete and imputed
datasets.

Based on the imputation accuracy performance, elastic net 0.2 1 by 1 method is
used to impute the missing values in the dataset. Then Bumphunter method is used to
detect DMRs among incomplete, complete and imputed data. As shown in Figure 3.5,
22 DMRs that overlap with the complete dataset are detected using the imputed data.
This is an improvement compared to only 19 common DMRs between the incomplete and
complete datasets. The number of potential false negative regions is reduced in the imputed
dataset compared to the incomplete dataset. At the same time, the imputed dataset reduced
the number of potential false positives to be only 1 compared to 7 using the incomplete
dataset. Since the analysis on real data is conducted on a short section of Chromosome 1,
these differences will accumulate when the entire genome is considered. More specifically,
compared to a section with around 8000 probes, the entire genome has about 60 times more
probes.
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3.5. RESULTS FO R SIM ULATED DATA
The simulated data are filtered by the criteria introduced in Section 2.1.1. Effects
are added to the 96 selected DMR clusters in the complete dataset with 36,279 probes.
Missing values are introduced to the 4,917 probes that are restored from the SNP data with
the missing rates of 20%, 50% and 70%. The imputation accuracy table and DMR detection
performance for the methods are given below.
3.5.1. Im putation accuracy. Table 3.5 shows the imputation accuracy for the sim
ulated data with 20% missing rate between the different imputation methods. The elastic
net 0.5, elastic net 0.8, elastic net 0.2 1 by 1 and elastic net 0.5 1 by 1 methods have the
lowest RMSE. The LASSO 1 by 1, elastic net 1 by 1 with mixing parameters 0.2, 0.5 and
0.8 methods have the lowest MAE. All the elastic net methods and LASSO 1 by 1 yield the
highest PCC. The elastic net 0.5 1 by 1 method has the lowest MAPE. For this missing rate,
the overall performance of elastic net 0.5 1 by 1 method is the best.
Table 3.5. Imputation accuracy for simulated data with 20% missing rate. The optimal
value(s) for each criteria are in bold.

mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1

RM SE

M AE

PC C

M APE

0.090
0.070
0.069
0.067
0.071
0.067
0.066
0.066
0.074
0.067
0.067
0.066
0.066
0.067

0.058
0.040
0.036
0.037
0.037
0.036
0.036
0.036
0.043
0.035
0.037
0.035
0.035
0.035

0.953
0.972
0.973
0.974
0.972
0.975
0.975
0.975
0.969
0.975
0.974
0.975
0.975
0.975

19.627
13.020
12.490
12.591
12.584
12.139
12.072
12.085
13.874
11.663
12.287
11.588
11.580
11.643
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Table 3.6 shows the imputation accuracy for simulated data with 50% missing rate.
In terms of RMSE, elastic net 0.5 and Ridge 1 by 1 methods perform the best. Elastic net 0.2
1 by 1 method yield the lowest MAE and MAPE. The elastic net (with mixing parameters
0.2, 0.5, 0.8), Ridge 1 by 1, and elastic net 0.2 1 by 1 methods have the highest PCC. Table
3.7 shows the imputation performance on simulated data with 70% missing rate. The Ridge
1 by 1 method has the lowest RMSE and highest PCC. The elastic net 0.2 1 by 1 method
has the lowest MAE and MAPE.
Table 3.6. Imputation accuracy for simulated data with 50% missing rate. The optimal
value(s) for each criteria are in bold.
RM SE

M AE

PC C

M APE

0.091
0.081
0.073
0.072
0.074
0.072
0.071
0.072
0.078
0.074
0.071
0.072
0.072
0.073

0.058
0.044
0.039
0.041
0.041
0.040
0.040
0.040
0.045
0.040
0.039
0.038
0.039
0.039

0.952
0.963
0.970
0.970
0.968
0.971
0.971
0.971
0.965
0.969
0.971
0.971
0.970
0.969

19.768
14.784
13.337
13.779
13.730
13.445
13.394
13.478
15.109
13.233
13.313
12.912
13.028
13.146

mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1

The average running times in seconds on a MacBook Pro with Processor 2.7 GHz
Intel Core i5 and Memory 8 GB 1867 MHz DDR3 over 30 runs for a select subset of the
imputation methods are recorded. One of the standard regularized imputation methods
(elastic net 0 .2), one of the 1 by 1 regularized imputation methods (elastic net 0.2 1 by 1)
and the methyLImp method are compared. Elastic net 0.2 methods are chosen because they
can represent other methods in the same method group, and their performance are stable
among different settings. The elastic net 0.2 1 by 1 method is the fastest, while the elastic
net 0.2 method is the slowest (Table 3.8).
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Table 3.7. Imputation accuracy for simulated data with 70% missing rate. The optimal
value(s) for each criteria are in bold.

mean
KNN
methyLImp
LASSO
Ridge
elastic net 0.2
elastic net 0.5
elastic net 0.8
FPCR
LASSO 1by1
Ridge 1by1
elastic net 0.2 1by 1
elastic net 0.5 1by1
elastic net 0.8 1by 1

RM SE

M AE

PC C

M APE

0.092
0.114
0.078
0.080
0.080
0.080
0.080
0.080
0.083
0.084
0.077
0.080
0.081
0.083

0.059
0.066
0.043
0.046
0.046
0.046
0.046
0.046
0.048
0.046
0.044
0.043
0.044
0.045

0.951
0.925
0.965
0.964
0.964
0.964
0.964
0.964
0.961
0.960
0.966
0.963
0.962
0.961

20.534
31.077
15.027
14.970
14.991
14.992
14.991
14.991
15.488
15.238
14.416
14.367
14.630
14.917

Table 3.8. Average running time in seconds over 30 runs
Average time (standard deviation)
elastic net 0.2
elastic net 0.2 1 by 1
methyLImp

540.62 (9.87)
57.87 (1.11)
59.99 (3.54)

Figure 3.6 provides a visualization of the RMSE verses the missing rate to compare
the standard and 1 by 1 regularized methods in both the real and simulated data. The
performance between the standard regularized imputation methods and the 1 by 1 methods
are similar, yet the 1 by 1 methods are much more computationally efficient. Thus only the
1 by 1 methods are further compared with other methods in Figure 3.7.
As a visualization and summary of Tables 3.2-3.7, Figure 3.7 compares the imputa
tion accuracy of mean imputation, methyLImp, FPCR imputation and the 1 by 1 regularized
methods with respect to RMSE for different missing rates in both the real and simulated
data. The KNN method is not included in the figure since the RMSE is inflated dramatically
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Real data Tumor group
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Figure 3.6. The root mean square error (RMSE) verses missing rate to compare the standard
regularized imputation methods and 1 by 1 regularized imputation methods. The standard
regularized imputation methods and the 1 by 1 methods have similar performance.
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when the missing rate is high. The mean imputation method has the highest RMSE in all
three datasets (real data Normal group, real data Tumor group and simulated data), followed
by the FPCR method. The FPCR imputation has the second highest RMSE in all three
datasets and for all missing rates, except for the simulated data at 70% missing rate. In
the simulated data group with 70% missing rate, FPCR outperforms mean and LASSO 1
by 1 methods. The methyLImp method is shown to have higher RMSE than all the 1 by 1
regularized methods in the real data Normal group with missing rate 20% and 50%, and it
only outperforms Ridge 1 by 1 and elastic net 0.8 1 by 1 methods with missing rate 70%.
In this dataset, elastic net 0.2 1 by 1 method has the lowest RMSE at all missing rates.
In the real data Tumor group, the elastic net methods have better performance in terms of
RMSE than methyLImp. In the simulated data, all the regularized methods outperform
methyLImp with 20% missing rate. Only the LASSO 1 by 1 method performed worse than
methyLImp with 50% missing rate. The elastic net 0.2 1 by 1 method works the best in
terms of MAE among all missing rates. When considering the overall imputation accuracy
results across all datasets, the elastic net 0.2 1 by 1 method is recommended since it provides
good performance and offers reasonable computational efficiency.
3.5.2.

DM R detection. Using the 1 by 1 elastic net method with 0.2 mixing param

eter recommended above, the DMR detection performance is assessed at the three different
missing rates. Two DMR detection methods (Bumphunter and DMRcate) are applied. The
regions detected as differentially methylated by both detection approaches are compared
with the simulated true DMRs. Two regions are counted as overlapping if they share any
common genomic locations on the chromosome. The relationship between two overlapping
regions could be exactly the same (Figure 3.8 a), one region lying within the other (Figure
3.8 b), or one region partially in common with the other (Figure 3.8 c). Alternatively, one
region can also overlap with multiple regions (Figure 3.8 d).
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Figure 3.7. The root mean square error (RMSE) verses missing rate to compare the different
imputation methods. The elastic net 0.2 1 by 1 method has good and stable performance
across the three datasets and different missing rates.
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Figure 3.8. Different cases of overlapping regions: a) two regions are exactly the same, b)
one region is within the other region, c) two regions have partial overlap, and d) one pink
region overlaps with two green regions.

There are 96 true DMRs. Figure 3.9 shows Venn Diagrams comparing the overlap in
detecting the true DMRs before and after imputation using the Bumphunter method for the
three different missing rates. Before imputation, using the data with missing entries, only
2 or 3 of the 96 DMRs can be found across the different missing rates. After imputation,
46 or 47 of the true DMRs can be detected. There are two numbers in the intersection of
the Venn Diagrams for the ‘After Imputation’ results because one true DMR is broken into
two regions, as shown in Figure 3.8 d. Using the Bumphunter method, the number of true
positives increases by 45 (2 to 47) with 20% missing rate, and 43 (3 to 46) with 50% and
70% missing rates. The number of false positives also increases by 22 with all missing
rates after the imputation method is applied. Figure 3.10 provides the results when the
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DMRcate method is used for DMR detection. The imputation step increased the number
of true positives by 86, 88 and 88 respectively for missing rates 20%, 50% and 70%, while
also increasing the number of false positives by 58, 80, and 81, respectively.

Figure 3.9. Venn diagrams to compare the DMRs found via the Bumphunter method before
(top row) and after (bottom row) imputation to the true DMRs for different missing rates.
When there are two numbers in the intersection, it means that one or more true regions are
detected as multiple regions. Numbers in parentheses represent the number of true regions.

The proposed imputation method improved the DMR detection results despite the
different DMR detection methods. To compare the DMR detection improvements among
the two methods, Figure 3.11 shows the detected DMRs using the imputed dataset by
Bumphunter method (blue) and DMRcate method (red) comparing to true DMRs (yellow)
at different missing rates. The counts in the Venn diagrams are recorded in terms of the
number of true DMRs in each part. These results show that the improvement on DMR
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DMR detection using DMRcate
Before imputation

True DMRs

Before imputation

True DMRs

Before imputation

True DMRs

After imputation

True DMRs

After imputation

True DMRs

After imputation

True DMRs

20% m issing rate

50% m issing rate

Figure 3.10. Venn diagrams to compare the DMRs found via the DMRcate method before
(top row) and after (bottom row) imputation to the true DMRs for different missing rates.
When there are two numbers in the overlapping part, it means that one or more true regions
are detected as multiple regions. Numbers in parentheses represent the number of true
regions.

detection by using the proposed imputation method is consistent for both DMR detection
methods.

All the true positive regions detected by Bumphunter are also detected by

DMRcate method at all missing rates.

3.6. DISCUSSION O F RESULTS
When analyzing the real data, the imputation accuracy shows an apparent difference
between Tumor group and Normal group. For example, using the same imputation method
elastic net 1 by 1 with mixing parameter 0 .2 , and the 20% missing rate, the imputation
accuracy in terms of RMSE is 0.059 in Normal group and 0.081 in Tumor group. The
worst RMSE for the Normal group is 0.085 while the best RMSE for the Tumor group
is 0.081. This may be caused by cancer heterogeneity. Previous research has shown the
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□ MR detection comparison between methods
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Figure 3.11. The detected DMRs using the imputed dataset by Bumphunter method (blue)
and DMRcate method (red) compared to true DMRs (yellow). The counts of true DMRs
are shown in the Venn diagrams.

existence of epigenetic heterogeneity among cancers (Liu et al., 2019; Teschendorff et al.,
2016; Fernandez et al., 2012). In the study of Fernandez et al. (2012), DNA methylation
profiles of 1505 CpG sites were examined on normal tissues and tumor tissues. It was
found that little variation exists in the DNA methylation patterns of normal tissues but there
was greater methylation heterogeneity among tumors. Hansen et al. (2011) suggested that
the epigenetic instability of essential genomic domains in tumor cells can lead to increased
methylation variability, and then contribute to cancer heterogeneity. The high variability in
the methylation levels in the Tumor group can lead to the low imputation accuracy.
The KNN imputation method performed poorly at missing rates 50% and 70% as
seen in Tables 3.3, 3.4, 3.6, and 3.7. The maximum percent of missing data allowed in each
variable is limited for the KNN method. When the percentage is over a threshold (usually
50%), the missing value will be imputed using the overall mean of each sample. With
a higher missing rate, KNN’s performance is even worse than mean imputation, because
the mean imputation uses the mean over all samples with complete entries of a particular
methylation site, while the KNN uses the mean over variables from the same sample.
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The functional principal component regression imputation methods does not per
form as well as the regularized linear regression imputation. The reason is likely due to the
large distance between probes. The human genome contains about 3 billion base pairs but
is covered by only around 450,000 probes on the microarray. Although probes are more
dense in some regions, on average neighboring probes may be too far away to maintain the
correlation mentioned in Section 2.1.2.
To summarize, the regularized linear regression imputation methods proposed in
this work have outperformed methyLImp in terms of RMSE, PCC and MAPE for the real
data under different missing rates. For simulated data, the regularized linear regression
imputation methods have better performance than methyLImp in terms of all four criteria
(RMSE, MAE, PCC and MAPE) under all missing rates. The 1 by 1 regularized methods
are more computationally efficient without much sacrifice in performance compared to the
regularized methods. The elastic net 0.2 1 by 1 method is recommended based on its
overall stable and good performance across most settings. While applying the imputation
methods for DMR analysis, true positive detection are improved. Although the number
of false positive detections also increased after imputation, the increase is small compared
to the increase of true positive detections. Take the 20% missing rate for example, using
the Bumphunter method, the number of true positives increased by 22.5 times (2 to 47)
while the number of false positives increased by 0.35 times (62 to 84). Using the DMRcate
method, the number of true positives increased by 21.5 times (4 to 90) while the number of
false positives increased by 0.60 times (97 to 155).
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4. CONCLUSION

4.1. SUMMARY
The filtering out of potential single nucleotide polymorphism (SNP) probes in the
preprocessing step of DNA differential methylation studies causes an unnecessary waste
of information. Incorporating SNP data into the DNA methylation analysis framework,
allows a large proportion of the probes to be restored. The effects of recovering those
probes are remarkable. The improvement on increasing the number of true DMRs has been
demonstrated by both the real data analysis and simulation studies, which only utilize part
of the genome. The effects will accumulate when the entire genome is considered.
In this research, SNP data are integrated with Infinium HumanMethylation450
BeadChip (HM450) methylation data to recover potential SNP-probes that do not actually
have SNPs and apply novel imputation methods for missing data due to true SNPs or
for other reasons. Missing data are categorized according to their missing mechanism as
missing completely at random, missing at random or missing not at random. Missing DNA
methylation data because of filtering is assumed to fall into the missing at random category.
Missing rates of 20%, 50% and 70% are used to develop and test the proposed methodology.
Imputation methods are proposed in Chapter 2 for DNA methylation data. Several
regularized regression methods are proposed, along with a functional data approach, and
compared to three existing methods. Previous studies have shown that methylation levels
are correlated with neighboring probes within short distances on the chromosome (Eckhardt
et al., 2006). It has also been found that the methylation levels are highly correlated with
other probes from the same sample (Zhang et al., 2015). This information can be used to aid
in imputing missing methylation levels. For each probe with missing values, submatrices
are extracted from the data to fit a regression model that is used to attain the imputed values.
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The model is fit by using the available data at the missing probe as the response variable and
data from other probes with complete information as the predictor variables. The imputation
steps in this research iteratively evaluate all subsets of probes with missing entries. The
input data is organized with each row representing a sample and each column representing
a probe. First a predictive model is built under the regularized linear regression framework,
then the missing values are imputed by prediction using complete entries of the same
sample. Ridge, LASSO and elastic net regression are explored as shrinkage approaches.
The tuning parameter that determines the amount of shrinkage for each model is selected
by cross validation. This step makes the computational speed slow because cross validation
is needed for each iteration. Therefore, variable screening before the regularization step
is recommended. Also, imputing the missing values site by site is recommended since
two sites may have different sets of most correlated predictors. The selection criteria for
including variables in the model is the Pearson correlation between the predictors and the
response variable. The number of probes used in the regression model is set to be the same
as the number of samples in the model. In an alternative approach, the measurements of
each sample are treated as one observation with a smooth curve representing the underlying
structure based on the correlation between neighboring probes of DNA methylation data.
Functional principal component analysis is performed and the component scores are used as
inputs into a functional linear regression model, which is used to perform the imputations.
The proposed imputation methods are evaluated and compared to existing methods
using both real and simulated data. A simulation study is conducted based on real data to
keep the natural structure of the DNA methylation data. Adjacent site clustering is applied
to reveal potential clusters (regions) using the normal samples of the real data. Among these
clusters, a subset is randomly selected in which known effects are added to differentiate
the two groups. Considering hyper- and hypomethylation patterns in the human genome
(Peters et al., 2015), two types of simulated regions are applied. For 50% of the clusters,
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the effect is added to the entire cluster. For the other 50% of the clusters, the effect is added
at the probe resolution, meaning that only the probe with high group mean will have the
effect added to the specific probe.
Performance of the proposed methods is assessed by two aspects. The first is the
imputation accuracy. The regularized methods have the best overall performance with
respect to imputation accuracy, followed by methyLImp, then FPCR imputation.

The

traditional imputation methods such as mean and KNN imputation perform worse. In terms
of computational efficiency, the regularized 1 by 1 approach is more efficient with similar
imputation accuracy as the regularized methods. The second way imputation performance
is evaluated is by investigating the impact on DMR detection. Using simulated data with
true DMRs known, imputation using the 1 by 1 approach for the elastic net with mixing
parameter 0.2 increased the number of true positives and decreased the number of false
negatives compared to analyzing the data without doing imputation. The number of false
positive detections also increased with the imputed dataset, but this increase was minimal
compared to the increase in true positive detections.

4.2. FU TU RE W O RK
In this research, efforts have been focused on restoring the probes that are filtered
out of HM450 data for the reason of potentially having a SNP. According to Table 3.1, high
detection p-values are another main reason for probe filtering. Those probes are removed
because they are carrying mainly noise instead of methylation information. Imputation and
simulation studies can be conducted to improve the DMR detection ability of the regions
involving those probes. Also, methods and theory can be tested and modified for other
types of DNA methylation data such as Illumina Infinium Methylation EPIC array and next
generation sequencing data. The FPCR method has a high potential to show improvement
on whole genome bisulfite sequencing (WGBS) data due to the comprehensive and dense
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coverage of the genome it provides.

The proposed methods in this study incorporate

the correlation between genomic variables into the imputation process, so they may be
generalized to other genomic data such as gene expression data.
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